0001683168-18-002356.txt : 20180815 0001683168-18-002356.hdr.sgml : 20180815 20180815164339 ACCESSION NUMBER: 0001683168-18-002356 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 68 CONFORMED PERIOD OF REPORT: 20180630 FILED AS OF DATE: 20180815 DATE AS OF CHANGE: 20180815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: YBCC, Inc. CENTRAL INDEX KEY: 0000822997 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MACHINERY, EQUIPMENT & SUPPLIES [5080] IRS NUMBER: 133367421 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-21384 FILM NUMBER: 181021450 BUSINESS ADDRESS: STREET 1: 17800 CASTLETON STREET STREET 2: SUITE 386 CITY: CITY OF INDUSTRY STATE: CA ZIP: 91748 BUSINESS PHONE: (626) 213-3945 MAIL ADDRESS: STREET 1: 17800 CASTLETON STREET STREET 2: SUITE 386 CITY: CITY OF INDUSTRY STATE: CA ZIP: 91748 FORMER COMPANY: FORMER CONFORMED NAME: INTERNATIONAL PACKAGING & LOGISTICS GROUP INC. DATE OF NAME CHANGE: 20080603 FORMER COMPANY: FORMER CONFORMED NAME: KAIRE HOLDINGS INC DATE OF NAME CHANGE: 19980323 FORMER COMPANY: FORMER CONFORMED NAME: INTERACTIVE MEDICAL TECHNOLOGIES LTD DATE OF NAME CHANGE: 19920703 10-Q 1 ybcc_10q-063018.htm QUARTERLY REPORT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended June 30, 2018 or

o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from _____________ to _____________

Commission file number 0-21384

YBCC, INC.

(Exact Name of Registrant as Specified in its Charter)

Nevada		13-3367421
(State or Other Jurisdiction of		(I.R.S. Employer
Incorporation or Organization)		Identification No.)

17800 Castleton Street, Suite 386, City of Industry, California

(Address of Principal Executive Offices)

91748

(Zip Code)

(626) 213-3945

(Registrant’s Telephone Number, Including Area Code)

___________________________________________

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

x Yes o No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one)

	Large accelerated filer o	Accelerated filer o

	Non-accelerated filer o	Smaller reporting company x

	Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Exchange Act Rule 12b-2 of the Exchange Act).

o Yes x No

The number of shares outstanding of the Issuer’s common stock as of August 14, 2018 was 9,894,214.

YBCC, Inc.

and Subsidiaries

FORM 10-Q for the Quarter Ended June 30, 2018

INDEX

		Page
PART I - FINANCIAL INFORMATION

Item 1.	Financial Statements (unaudited)		3

	Condensed Consolidated Balance Sheets as of June 30, 2018 and December 31, 2017		3

	Condensed Consolidated Statements of Operations and Comprehensive Loss for the Three and Six Months Ended June 30, 2018 and 2017		4

	Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2018 and 2017		5

	Notes to Condensed Consolidated Financial Statements		6

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		16

Item 3.	Quantitative and Qualitative Disclosures About Market Risk		19

Item 4.	Controls and Procedures		20

PART II - OTHER INFORMATION

Item 1.	Legal Proceedings		21

Item 1A.	Risk Factors		21

Item 2.	Unregistered Sale of Equity Securities and Use of Proceeds		21

Item 3.	Defaults Upon Senior Securities		21

Item 4.	Mine Safety Disclosures		21

Item 5.	Other Information		21

Item 6.	Exhibits		22

Signatures			23

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

YBCC, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

	June 30, 2018			December 31, 2017
	(unaudited)
Assets
Current assets
Cash and cash equivalents	$	91,329		$	369,607
Accounts receivable - net		5,814			–
Accounts receivable - related party		182,365			–
Inventory		373,860			127,335
Other receivable		86,989			33,251
Advance to suppliers		73,223			20,007
Prepaid expenses		39,785			50,753
Total current assets		853,365			600,953

Property, plant, and equipment - net		2,479,247			2,538,580
Intangible assets - net		706,157			726,043
Deposits		6,005			6,052

Total assets	$	4,044,774		$	3,871,628


Liabilities and Equity

Current liabilities
Accounts payable	$	187,924		$	160,625
Accrued expenses		140,098			124,714
Customer deposits		213,628			31,314
Taxes payable		101,286			92,122
Other payable		244,475			313,806
Other payable-related parties		2,868,321			2,900,912
Loan payable		84,629			–
Total current liabilities		3,840,361			3,623,493
Total liabilities		3,840,361			3,623,493

Equity
Convertible preferred shares: $0.0001 par value, 50,000,000 shares authorized, 974,370 series A issued and outstanding as of June 30, 2018 and December 31, 2017, respectively		98			98
Common stock: $0.001 par value, 900,000,000 shares authorized, 9,894,214 shares issued and outstanding as of June 30, 2018 and December 31, 2017, respectively		9,894			9,894
Additional paid in capital		1,162,328			1,162,328
Accumulated foreign currency exchange loss		(43,288	)		(36,581	)
Accumulated deficit		(1,250,396	)		(1,179,676	)
Total YBCC, Inc stockholders' equity		(121,364	)		(43,937	)
Non-controlling interest		325,777			292,072
Total equity		204,413			248,135
Total liabilities and equity	$	4,044,774		$	3,871,628

See accompanying notes to these unaudited condensed consolidated financial statements

YBCC, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

FOR THE THREE MONTHS AND SIX MONTHS PERIOD ENDED JUNE 30, 2018 AND 2017

(UNAUDITED)

	For The Three Months Ended June 30,						For The Six Months Ended June 30,
	2018			2017			2018			2017
Revenue	$	674,441		$	606,693		$	935,621		$	886,534

Cost of goods sold		478,897			562,699			698,150			840,716

Gross profit		195,544			43,994			237,471			45,818

Operating expenses
Selling expenses		7,168			5,120			10,248			13,122
General & administrative expenses		124,843			162,604			268,853			344,001
Total operating expenses		132,011			167,724			279,101			357,123

Income (loss) from operation		63,533			(123,730	)		(41,630	)		(311,305	)

Other income (expenses)
Other income (expense)		15,958			(6	)		10,927			2,964
Interest income		133			67			133			102
Total other income		16,091			61			11,060			3,066

Income (loss) before income taxes		79,624			(123,669	)		(30,570	)		(308,239	)
Provision for income tax		–			–			–			–
Net Income (Loss)		79,624			(123,669	)		(30,570	)		(308,239	)

Less: net income (loss) attributable to non-controlling interest		60,488			(13,077	)		40,149			(48,905	)
Net income (loss) attributable to the Company	$	19,136		$	(110,593	)	$	(70,719	)	$	(259,335	)

Net Income (Loss)		79,624			(123,669	)		(30,570	)		(308,239	)

Other Comprehensive Income
Foreign currency translation gain (loss)		(24,249	)		8,315			(13,152	)		13,716

Comprehensive income (loss)		61,819			(115,354	)		(37,278	)		(294,523	)

Less: comprehensive income (loss) attributable to non-controlling interest		(11,882	)		4,074			(6,444	)		6,721
Net comprehensive income (loss) attributable to the Company	$	73,701		$	(119,428	)	$	(30,834	)	$	(301,244	)

Net income (loss) per share - basic& diluted	$	0.01		$	(0.01	)	$	(0.00	)	$	(0.03	)

Weighted average shares outstanding - basic & diluted		9,894,214			9,891,214			9,894,214			9,861,065

See accompanying notes to these unaudited condensed consolidated financial statements

YBCC, INC., AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE SIX MONTHS PERIOD ENDED JUNE 30, 2018 AND 2017

(Unaudited)

	For The Six Months Ended June 30,
	2018			2017
Cash flows used in operating activities
Net Loss		(30,570	)		(308,239	)

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation		115,126			98,708
Amortization		8,035			7,443

Changes in operating assets and liabilities:
Accounts receivable		(6,044	)		7,510
Accounts receivable - related party		(189,573	)		–
Other receivable		(58,154	)		12,044
Advance to suppliers		(55,668	)		(37,957	)
Prepaid expenses		10,871			6,882
Inventory		(258,486	)		(58,107	)
Deposits		–			(146	)
Accounts payable		31,173			3,194
Accounts payable - related party		–			71,272
Accrued expense		15,639			12,773
Customer deposit		190,065			14,697
Customer deposit - related party		–			(34,736	)
Tax payable		11,130			14,431
Other payable		(66,609	)		(62,270	)
Cash used in operating activities		(283,065	)		(252,501	)

Cash flow used in investing activities:
Deferred cost		–			14,946
Purchase of property and equipment		(19,028	)		(23,387	)
Construction in process		(78,548	)		–
Cash used in investing activities		(97,576	)		(8,441	)

Cash flow provided by (used in) financing activities:
Advance from (repayment to) related party		9,693			(148,426	)
Proceeds from short term borrowing		87,974			97,532
Net cash provided by (used in) financing activities		97,667			(50,894	)

Effects of currency translation on cash and cash equivalents		4,696			460

Net decrease in cash and cash equivalents		(278,278	)		(311,379	)
Cash and cash equivalents at beginning of period		369,607			339,147
Cash and cash equivalents at end of period		91,329			27,768

Supplementary Disclosures of Cash Flow
Cash paid during the year for
Income taxes	$	–		$	–
Interest	$	–		$	–

Non-cash investing and financing activities:
Issuance of common stock for subscription received previously	$	–		$	300,000

See accompanying notes to these unaudited condensed consolidated financial statements

ybcc, Inc. and Subsidiaries

Notes to Unaudited Condensed Consolidated Financial Statements

NOTE 1 - ORGANIZATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Organization and Operations – YBCC, Inc., (The “Company” or “YBAO”), formerly known as International Packaging and Logistic Group, Inc., a Nevada corporation, was originally incorporated on June 2, 1986, in the state of Delaware. On April 17, 2008, the Company redomiciled form the State of Delaware to the State of Nevada.

On July 2, 2007, the Company through its wholly-owned subsidiary, YesRx.com (“YesRx”) acquired all the outstanding shares of H&H Glass, Inc. (“H&H Glass”), in exchange for 3,915,000 shares of its common stock in a reverse triangular merger.

On May 15, 2016, the Company and Xiuhua Song (the “Purchaser”) entered into a Stock Purchase Agreement (the “Purchase Agreement”), pursuant to which IPLO (the “Seller”) would sell to the Purchaser, and the Purchaser will purchase from the Seller, an aggregate of 3,915,000 newly issued shares of IPLO Common Stock (the “Shares”), which Shares represented 87% of the issued and outstanding shares of common stock. On July 1, 2016, this transaction was completed.

On July 1, 2016, Standard Resources Ltd. (“Standard”), previously IPLO’s majority stockholder, and IPLO entered into a share purchase agreement (“H&H Vend Out”) whereby Standard would cancel 3,915,000 shares of IPLO common stock held by it in exchange for all of the outstanding shares of H&H Glass. The H&H Glass Vend Out was completed on August 31, 2016.

On July 1, 2016, the Company executed a Share Exchange Agreement (“Exchange Agreement”) by and among Yibaoccyb Limited, a British Virgin Islands limited liability company (“Yibaoccyb”), and the stockholders of 51% of Yibaoccyb’s common stock (the “Yibaoccyb Shareholders”), on the one hand, and the Company, on the other hand. Yibaoccyb owns 100% of YibaoConfucian Co., Ltd. (“YibaoHK”), a Hong Kong company. YibaoHK will own 100% of Shenzhen Confucian Biologics Co. Ltd. (yet to be formed, “Yibao”), which will be a wholly foreign-owned enterprise (“WFOE”) under the laws of the Peoples’ Republic of China (“PRC” or “China”). On August 31, 2016, YibaoHK entered into a series of contractual arrangements with Shandong Confucian Biologics Co., Ltd. (“Confucian”) which is a limited liability company headquartered in, and organized under the laws of, the PRC. The contractual arrangements are discussed below.

The Exchange Agreement was completed on August 31, 2016 concurrent with the H&H Vend Out. The Company issued 2,040,000 shares of the Company’s common stock (the “IPLO Shares”) to the Yibaoccyb Shareholders in exchange for 51% of the common stock of Yibaoccyb.

On December 22, 2016, the Company amended its Certificate of Incorporation (the “Amendment”). As a result of the Amendment, the Company’s corporate name was changed from International Packaging and Logistics Group, Inc. to YBCC, Inc.

Yibaoccyb is a limited liability company incorporated under the laws of the British Virgin Islands on May 30, 2016. Other than all the issued and outstanding shares of YibaoHK, Yibaoccyb has no other assets or operations.

YibaoHK is a limited liability company incorporated under the laws of the Hong Kong on June 15, 2016, which was formed by Yibaoccyb.

Confucian was founded on October 31, 2012. Confucian is in the Food Industrial Park inside the economic development Zone of JinXiang County, Jining City in the province of Shandong in China.

Confucian possesses manufacturing permits for food product, hygienic products, sanitary products, and health products. The Company's main business includes research and development of chondroitin and garlic oil; trading, cold storage, and pretreating of garlic, fruit, and vegetables products; trading of chemical products (excluding hazardous chemicals); import and export of goods and technology (excluding those restricted by China government); and, the manufacturing and sale of health products including powder, granules, tablets, hard capsule, soft capsule products.

Details of the Company’s structure as of June 30, 2018 is as follow:

Reverse Merger Accounting – Since YBCC and Yibaoccyb were entities under Ms. Song’s common control prior to the share exchange, the transaction was accounted for as a restructuring transaction in accordance with generally accepted accounting principles in the United States ("GAAP"). YBCC has recast prior period unaudited consolidated financial statements to reflect the conveyance of Yibaoccyb’s common shares as if the restructuring transaction had occurred as of the earliest date of the unaudited consolidated financial statements.

Basis of Presentation - The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and note disclosures required by U.S. generally accepted accounting principles (“U.S. GAAP”) for complete audited financial statements. The accompanying unaudited financial information should be read in conjunction with the audited consolidated financial statements, including the notes thereto, as of and for the year ended December 31, 2017, included in our 2017 Annual Report on Form 10-K filed with the SEC. The information furnished in this report reflects all adjustments (consisting of normal recurring adjustments), which are, in the opinion of management, necessary for a fair presentation of our financial position, results of operations and cash flows for each period presented. The results of operations for the six months ended June 30, 2018 are not necessarily indicative of the results for the year ending December 31, 2018 or for any future period.

Principles of Consolidation - The unaudited condensed consolidated financial statements include the accounts of YBCC and its subsidiaries. The Company’s subsidiaries include 51% of Yibaoccyb, YibaoHK and Confucian, of which 49% of Yibaoccyb’s consolidated operating results was shown in non-controlling interest on the consolidated balance sheets.

Intercompany accounts and transactions have been eliminated upon consolidation.

Use of Estimates - The preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimate and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. The most significant estimates reflected in the condensed consolidated financial statements include allowance for doubtful accounts, allowance for inventory, depreciation, useful lives of property and equipment, deferred income taxes, useful life of intangible assets, and contingencies. Estimates and assumptions are periodically reviewed and the effects of revisions are reflected in the unaudited condensed consolidated financial statements in the period they are determined to be necessary.

Inventories - Inventory is valued at the lower of cost or market. Cost is determined using first-in, first-out method.

Inventory, comprised principally of finished goods, raw material and packaging material, are valued at the lower of cost or market.

	June 30, 2018		December 31, 2017
Finished goods	$	14,502	$	7,106
Work in progress		96,512		47,292
Raw materials		225,671		46,902
Packaging material		37,175		26,035
Total	$	373,860	$	127,335

The Company periodically estimates an inventory allowance for estimated unmarketable inventories. Inventory amounts are reported net of such allowances, if any. There were no allowances for inventory as of June 30, 2018 and December 31, 2017.

Revenue Recognition - The Company recognizes product revenue in accordance with ASC 606. The core principle of ASC 606 is that an entity should recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve the core principle of ASC 606, an entity should take the following actions: Step 1: Identify the contract with a customer; Step 2: Identify the performance obligations in the contract; Step 3: Determine the transaction price; Step 4: Allocate the transaction price; Step 5: Recognize revenue when or as the entity satisfies a performance obligation. The Company complies with ASC 606 revenue recognition and follows the five-step revenue recognition model along with other guidance impacted by this standard.

Impairment of Long-Live Assets – The Company applies FASB ASC 360, “Property, Plant and Equipment,” which addresses the financial accounting and reporting for the recognition and measurement of impairment losses for long-lived assets. In accordance with ASC 360, long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company will recognize the impairment of long-lived assets in the event the net book value of such assets exceeds the future undiscounted cash flows attributable to those assets. There is no impairment of our long-lived assets for the six months ended June 30, 2018 and 2017.

Foreign Currency Translation - The Company's functional currency is the Chinese Renminbi (RMB). The reporting currency is that of the US Dollar. Assets, liabilities and owners’ contribution are translated at the exchange rates as of the balance sheet date. Income and expenditures are translated at the average exchange rate of the year. The RMB is not freely convertible into foreign currency and all foreign currency exchange transactions must take place through authorized institutions. No representation is made that the RMB amounts could have been, or could be, converted into US dollar at the rates used in translation.

The exchange rates used to translate amounts in RMB into USD for the purposes of preparing the financial statements were as follows:

Balance sheet
Balance sheet as of June 30, 2018	RMB 6.62 to US $1.00
Balance sheet as of December 31, 2017	RMB 6.51 to US $1.00

Statement of operation and other comprehensive income
Statement of operation and other comprehensive income for three months ended June 30, 2018	RMB 6.38 to US $1.00
Statement of operation and other comprehensive income for three months ended June 30, 2017	RMB 6.86 to US $1.00
Statement of operation and other comprehensive income for six months ended June 30, 2018	RMB 6.37 to US $1.00
Statement of operation and other comprehensive income for six months ended June 30, 2017	RMB 6.87 to US $1.00

Fair Value of Financial Instruments – FASB ASC 820, “Fair Value Measurement” specifies a hierarchy of valuation techniques based upon whether the inputs to those valuation techniques reflect assumptions other market participants would use based upon market data obtained from independent sources (observable inputs). In accordance with ASC 820, the following summarizes the fair value hierarchy:

Level 1 Inputs— Unadjusted quoted market prices for identical assets and liabilities in an active market that the Company has the ability to access.

Level 2 Inputs— Inputs other than the quoted prices in active markets that are observable either directly or indirectly.

Level 3 Inputs— Inputs based on valuation techniques that are both unobservable and significant to the overall fair value measurements

ASC 820 requires the use of observable market data, when available, in making fair value measurements. When inputs used to measure, fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.

The Company did not identify any assets or liabilities that are required to be presented at fair value on a recurring basis. Carrying values of non-derivative financial instruments, including cash and cash equivalents, accounts receivable, inventories, prepaid expenses, advances from customers, accounts payable, taxes payable, accrued liabilities and other payables, and loan from bank, approximated their fair values due to the short maturity of these financial instruments. There were no changes in methods or assumptions during the periods presented.

Net Earnings (Loss) Per Share – Earnings/(loss) per common share is computed on the weighted average number of common shares outstanding during each year. Basic earnings per share is computed as net loss applicable to common stockholders divided by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflects the potential dilution that could occur from common shares issuable through convertible preferred shares, stock options, warrants and other convertible securities when the effect would be dilutive. In this case, the Preferred Shares would not be dilutive since the conversion price is $3.00 and the quoted price is significantly lower than the conversion price. Therefore, there were no dilutive securities for the six months ended June 30, 2018 and 2017, respectively.

Reclassifications – Certain classifications have been made to the prior year consolidated financial statements to conform to the current year presentation. The reclassification had no impact on previously reported net loss or accumulated deficit.

Recent Accounting Pronouncements

In May 2014, the FASB issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers (Topic 606),” (“ASU 2014-09”). ASU 2014-09 supersedes the revenue recognition requirements in ASC 605 - Revenue Recognition (“ASC 605”) and most industry-specific guidance throughout ASC 605. The FASB has issued numerous updates that provide clarification on a number of specific issues as well as requiring additional disclosures. The core principle of ASC 606 requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. ASC 606 defines a five-step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing U.S. GAAP including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The guidance also requires enhanced disclosures regarding the nature, amount, timing and uncertainty of revenue and cash flows arising from an entity’s contracts with customers. The guidance may be adopted through either retrospective application to all periods presented in the financial statements (full retrospective approach) or through a cumulative effect adjustment to retained earnings at the effective date (modified retrospective approach). The Company had evaluated the effected that will result from adopting the guidance in this standard and concluded that the new revenue standards are not expected to have a material impact on the amount and timing of revenue recognized in the Company’s consolidated financial statements.

In November 2016, the FASB issued ASU 2016-18, “Statement of Cash Flows (Topic 230): Restricted Cash”. These amendments require that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. As a result, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The amendments do not provide a definition of restricted cash or restricted cash equivalents. The amendments in this ASU are effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted. The amendments should be applied using a retrospective transition method to each period presented. The Company has evaluated the impact of adopting ASU 2016-18 noting it will only impact the Company to the extent it has restricted cash in the future.

In July 2017, the FASB issued ASU 2017-11, Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception. For public business entities, the amendments in Part I of this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. For all other entities, the amendments in Part I of this Update are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted for all entities, including adoption in an interim period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. The amendments in Part II of this Update do not require any transition guidance because those amendments do not have an accounting effect. The Company is currently in the process of evaluating the impact of the adoption on its consolidated financial statements.

In February 2018, the FASB issued ASU No. 2018-02 Income Statement—Reporting Comprehensive Income (Topic 220)—Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. The amendments in this Update allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act of 2017. The amendments in this Update affect any entity that is required to apply the provisions of Topic 220, Income Statement-Reporting Comprehensive Income, and has items of other comprehensive income for which the related tax effects are presented in other comprehensive income as required by GAAP. The Company is currently in the process of evaluating the impact of the adoption on its consolidated financial statements.

The Company has considered all new accounting pronouncements and has concluded that there are no new pronouncements that may have a material impact on results of operations, financial condition, or cash flows, based on current information.

NOte 2 - going concern

Net income and net losses for the three months ended June 30, 2018 and 2017 were $79,624 and $123,669, respectively. The Company sustained net losses of $30,570 and $308,239 during the six months ended June 30, 2018 and 2017, respectively. The Company has accumulated deficit of $1,250,396 and $1,179,676 as of June 30, 2018 and December 31, 2017, respectively. The Company’s continuation as a going concern is dependent on its ability to generate sufficient cash flows from operations to meet its obligations and/or obtain additional financing, as may be required.

The accompanying unaudited condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern; however, the above condition raises substantial doubt about the Company’s ability to do so. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern.

Management’s Plan to Continue as a Going Concern

In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management’s plans to obtain such resources for the Company include (1) obtaining capital from the sale of its equity securities, (2) sales of the Company’s products, (3) short-term and long-term borrowings from banks, and (4) short-term borrowings from stockholders or other related party(ies) when needed. However, management cannot provide any assurance that the Company will be successful in accomplishing any of its plans.

The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually to secure other sources of financing and attain profitable operations.

NOte 3 - concentration of credit risk

We maintain our cash balance in several banks in China and United States. The consolidated cash balances as of June 30, 2018 and December 31, 2017 were $91,329 and $369,607, respectively. The cash balances in China as of June 30, 2018 and December 31, 2017 were $53,213 and $307,361, respectively. The accounts in China were not insured which we believe were exposed to credit risks on cash. As of June 30, 2018, the balance of our US account was $38,116 which is within federal insured limit of $250,000. As of December 31, 2017, the balance of our US account was $62,246, which is within federal insured limit of $250,000.

NOTe 4 - other receivable

Total other receivable consists of balances of VAT receivable of $17,353 and $33,251 as of June 30, 2018 and December 31, 2017, respectively and other temporary funding receivable from a third party of $69,636 and $0 as of June 30, 2018 and December 31, 2017, respectively. The temporary funding was transferred to the Company’s consulting firm, which makes payments of operating expenses on behalf of the Company.

NOTe 5 - prepaid expenses

Prepaid expenses were comprised of the following:

	June 30, 2018		December 31, 2017
Utilities	$	1,511	$	1,537
Professional fees		38,274		44,974
Other		–		4,242
Total	$	39,785	$	50,753

Note 6 - property, plant and equipment

Property, plant and equipment as of June 30, 2018 and December 31, 2017 are summarized as following:

	June 30, 2018			December 31, 2017
Buildings	$	1,825,466		$	1,858,989
Vehicles		11,712			11,912
Manufacturing equipment		1,132,377			1,133,045
Office equipment		92,474			93,961
Construction in process		77,956			–
Property, plant, and equipment - total		3,139,985			3,097,907
Less: accumulated depreciation		(660,738	)		(559,327	)
Fixed assets, net	$	2,479,247		$	2,538,580

For the three months ended June 30, 2018 and 2017, depreciation expenses were $57,623 and $49,794, respectively. For the six months ended June 30, 2018 and 2017, depreciation expenses were $115,126 and $98,708, respectively.

note 7 - intangible assets -net

All land in the PRC is owned by the government and cannot be sold to any individual or entity. Instead, the government grants landholders a "land use right" after a purchase price for such "land use right" is paid to the government. The "land use right" allows the holder to use the land for 50 years and enjoys all the incidents of ownership of the land. As of June 30, 2018 and December 31, 2017, the land use rights net of accumulated amortization was $706,157 and $726,043, respectively. The use term was 50 years.

The summary of land use rights as of June 30, 2018 and December 31, 2017 are summarized as following:

The land use right term	June 30, 2018			December 31, 2017
May, 2013 - Apr. 2063	$	544,066		$	553,332
Dec. 2015 - Sept. 2065		204,017			207,491
Dec. 2015 – Sept. 2065		24,830			25,252
Intangible assets- total		772,913			786,075
Less: accumulated amortization		(66,756	)		(60,032	)
Intangible assets, net	$	706,157		$	726,043

For the three months ended June 30, 2018 and 2017, amortization expenses were $4,010 and $3,729, respectively. For the six months ended June 30, 2018 and 2017, amortization expenses were $8,035 and $7,443, respectively.

NOTE 8 - COMMITMENTS AND CONTINGENCIES

The Company’s current lease is in City of Industry, California. The lease period started on October 1, 2016 and expires on September 1, 2018. On October 1, 2016, the Company started this lease at $2,802 per month from October 1, 2016 to September 1, 2017. From September 2, 2017 to August 31, 2018, the monthly lease is $3,063, resulting in the following future commitments:

	Amount
2018 calendar year	$	6,126
Total	$	6,126

NOTE 9 - INCOME TAX

At June 30, 2018 and December 31, 2017, based on the weight of available evidence, management determined that it was unlikely that the Company's deferred tax assets would be realized and have provided for a full valuation allowance associated with the net deferred tax assets.

The Company periodically analyzes its tax positions taken and expected to be taken and has determined that since inception there has been no need to record a liability for uncertain tax positions. The Company classifies income tax penalties and interest, if any, as part of selling, general and administrative expenses in the accompanying statements of operations. There was no accrued interest or penalties as of June 30, 2018 and December 31, 2017.

The Company is neither under examination by any taxing authority, nor has it been notified of any impending examination.

Under the Law of People’s Republic of China on Enterprise Income Tax (“EIT Law”), which was effective from January 1, 2008, domestically-owned enterprises and foreign-invested enterprises are subject to a uniform tax rate of 25%. The potential benefit of the Company’s net operating losses has not been recognized in these financial statements because it is more likely-than-not the Company will not utilize the net operating losses carried forward as it does not expect to generate sufficient taxable income in future or the amount involved is not significant.

	June 30, 2018			December 31, 2017
Current
USA	$	–		$	–
China		–			–

Deferred
USA
Deferred tax assets for NOL carryforwards		23,626			37,893
Valuation allowance		(23,626	)		(37,893	)
Net changes in deferred income tax under non-current portion		–			–

China
NOL carryforwards		(20,484	)		18,256
Valuation allowance		20,484			(18,256	)
Net changes in deferred income tax under non-current portion		–			–

Total provision for income tax	$	–		$	–

The tax effects of temporary differences that gave rise to significant portions of deferred tax assets at June 30, 2018 and December 31, 2017 are as follows:

	June 30, 2018			December 31, 2017
Deferred Tax Assets:
Net operating loss carry forwards	$	330,451		$	327,310
Valuation allowance		(330,451	)		(327,310	)
Net deferred tax assets	$	–		$	–

A reconciliation between the income tax computed at the U.S. statutory rate and the Company’s provision for income tax in the PRC is as follows:

	June 30, 2018			December 31, 2017
Tax expense at statutory rate-US		21%			34%
Foreign income not recognized in the US		(21%	)		(34%	)
PRC enterprise income tax rate		25%			25%
Loss not subject to income tax		(25%	)		(25%	)
Effective income tax rates		–			–

On December 22, 2017, the Tax Cuts and Jobs Act (the Tax Act) was enacted, significantly altering U.S. corporate income tax law. The SEC issued Staff Accounting Bulletin 118, which allows companies to record reasonable estimates of enactment impacts where all of the underlying analysis and calculations are not yet complete. The provisional estimates must be finalized within a one-year measurement period. The Company reduced its net domestic deferred tax asset balance by $88,781 due to the reduction in corporate tax rate from 34% to 21%. These adjustments are fully offset by a change in the Company’s U.S. valuation allowance.

note 10 - equity

Common Stock:

On July 1, 2016, the Company issued 3,915,000 shares of common stock to Ms. Song in connection with the change of control.

On August 31, 2016, the Company cancelled 3,915,000 shares of outstanding shares belonging to Standard.

On August 31, 2016, the Company issued 2,040,000 shares to Yibaoccyb Shareholders in exchange for 51% of the common stock of Yibaoccyb to complete the share exchange and restructuring of entities under common control.

On December 22, 2016, the Company issued 350,000 shares for legal counsel services valued at $35,000.

On December 23, 2016, the Company received cash payment of $300,000 in advance for issuance of 3,000,000 shares of common stock, or $0.10 per share. On January 3, 2017, 3,000,000 shares were issued to seven investors, none of which is a related-party to the Company.

As a result of all common stock issuances, the total issued and outstanding shares of common stock were 9,894,214 as of June 30, 2018 and December 31, 2017, respectively.

Series A Preferred Shares:

The Series A Preferred shares are convertible into common shares on a 1:1 ratio at a fixed rate of $3 per share. Preferred shares have no voting rights, have no redemption rights and earn no dividends. Holders of Series A Convertible Preferred Stock are not permitted to convert their stock into common shares until the Company’s market capital reaches $15,000,000. Upon dissolution, liquidation or winding up of the Company, whether voluntary or involuntary, the holders of the then outstanding shares of Series A Convertible Preferred Stock shall be entitled to receive out of the assets of the Company the sum of $0.0001 per share (the “Liquidation Rate”) before any payment or distribution shall be made on any other class of capital stock of the Company ranking junior to the Series A Convertible Preferred Stock.

ASC Topic 480, “Distinguishing Liabilities from Equity,” establishes standards for how an issuer classifies and measures certain financial instruments with characteristics of both liabilities and equity.

A mandatorily redeemable financial instrument shall be classified as a liability unless the redemption is required to occur only upon the liquidation or termination of the reporting entity. A financial instrument issued in the form of shares is mandatorily redeemable if it embodies an unconditional obligation requiring the issuer to redeem the instrument by transferring its assets at a specified or determinable date (or dates) or upon an event certain to occur. A financial instrument that embodies a conditional obligation to redeem the instrument by transferring assets upon an event not certain to occur becomes mandatorily redeemable—and, therefore becomes a liability—if that event occurs, the condition is resolved, or the event becomes certain to occur.

The Company determined that the preferred shares are not mandatorily or conditionally redeemable and are properly classified as permanent equity in the accompanying unaudited condensed consolidated financial statements.

NOTE 11 - NON-CONTROLLING INTEREST

On July 1, 2016, the Company executed the Exchange Agreement with Yibaoccyb and the Yibaoccyb Shareholders. From and after the Closing Date, Yibaoccyb became a 51% owned subsidiary of the Company. Yibaoccyb owns 100% of YibaoHK. YibaoHK will own 100% of Shenzhen Confucian Biologics Co. Ltd. (yet to be formed, “Yibao WFOE”), which will be wholly foreign-owned enterprise (“WFOE”) under the laws of the Peoples’ Republic of China (“PRC” or “China”). On August 31, 2016, YibaoHK entered into a series of contractual arrangements with Confucian and currently is 100% owner of Confucian.

Non-controlling interest consisted of the following:

	June 30,			December 31,
	2018			2017
Beginning balance	$	292,072		$	304,291
Net income (loss) attributed to non-controlling interest		40,149			(31,538	)
Foreign currency translation gain (loss) attributable to non-controlling interest		(6,444	)		19,319
Ending balance	$	325,777		$	292,072

note 12 - related party transactions

The related parties of the Company with whom transactions are reported in these financial statements are as follows:

Name of Entity or Individual		Relationship with the Company and subsidiaries
Shandong Yibao Biologics Co, Ltd		Affiliated company with common shareholders
Shandong Yibao Import & Export Trading Co, Ltd		Affiliated company with common shareholders
Ms. Xiuhua Song		Director and controlling beneficiary shareholder of the Company
Mr. Hengchun Zhang		Owner of Shandong Confucian Biologics
Mr. Qingbao Kong		Ms. Xiuhua Song’s spouse

Transactions:

	For the Six Months Ended June 30,
	2018		2017
Sales to Shandong Yibao Biologics Co. Ltd	$	589,651	$	105,476
Sales to Shandong Yibao Import & Export Trading Co. Ltd		–	$	45,399
Total	$	589,651	$	150,875

	For the Six Months Ended June 30,
	2018		2017
Purchase from Shandong Yibao Biologics Co. Ltd	$	–	$	113,771
Total	$	–	$	113,771

Accounts receivable from related party

	June 30, 2018		December 31, 2017
Accounts receivable from Shandong Yibao Biologics Co. Ltd	$	182,365	$	–
Total	$	182,365	$	–

Due to related parties

	June 30, 2018		December 31, 2017
To Xiuhua Song	$	2,602,842	$	2,630,912
To Hengchun Zhang		265,479		270,000
Total	$	2,868,321	$	2,900,912

NOTE 13 - MAJOR SUPPLIERS AND CUSTOMERS

The Company purchases majority of its inventory and packaging supplies from one supplier which accounted for 22.96% of the total purchases for the six months ended June 30, 2018.

The Company had three major customers for the six months ended June 30, 2018: Shandong Yibao Biologics, a related party, accounted for 54.12% of revenue, Anhui Xiancheng Import and Export Company accounted for 26.30% of revenue, Ping Xiang Import and Export Company accounted for 12.35% of revenue for the six months ended June 30, 2018.

The Company purchases majority of its inventory and packaging supplies from three suppliers which accounted for 31.16%, 23.83% and 15.43% of the total purchases for the six months ended June 30, 2017.

The Company had four major customers for the six months ended June 30, 2017: Ping Xiang Import and Export Company accounted for 22.65% of revenue, Jiangshan Huacheng Import and Export Company accounted for 20.01%, Nanjing Hejian Biologics accounted for 15.98%, and Shandong Yibao Biologics for 11.90% of revenue for the six months ended June 30, 2017.

NOTE 14 - SUBSEQUENT EVENTS

Management has evaluated subsequent events through August 14, 2018, the date which the condensed consolidated financial statements were available to be issued. All subsequent events requiring recognition as of June 30, 2018 have been incorporated into these condensed consolidated financial statements and there are no subsequent events that require disclosure in accordance with FASB ASC Topic 855, “Subsequent Events.”

ITEM 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

The information contained in this Form 10-Q is intended to update the information contained in our Annual Report on Form 10-K for the year ended December 31, 2017 and presumes that readers have access to, and will have read, the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and other information contained in such Form 10-K. The following discussion and analysis also should be read together with our financial statements and the notes to the financial statements included elsewhere in this Form 10-Q.

The following discussion contains certain statements that may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements appear in a number of places in this Report, including, without limitation, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” These statements are not guarantees of future performance and involve risks, uncertainties and requirements that are difficult to predict or are beyond our control. Forward-looking statements speak only as of the date of this quarterly report. You should not put undue reliance on any forward-looking statements. We strongly encourage investors to carefully read the factors described in our Annual Report on Form 10-K for the year ended December 31, 2017 in the section entitled “Risk Factors” for a description of certain risks that could, among other things, cause actual results to differ from these forward-looking statements. We assume no responsibility to update the forward-looking statements contained in this quarterly report on Form 10-Q. The following should also be read in conjunction with the unaudited condensed consolidated Financial Statements and notes thereto that appear elsewhere in this report.

Overview

The Company is a manufacture and research based bio-science company. It has large capacity in manufacturing tablets, granule, oral liquid, powders, soft gels and capsules products. The Company distributes its products through its own network and white label products. It also has access to a member-based distribution system owned by its affiliated company.

The Company possesses manufacturing permits for food product, hygienic products, sanitary products, and health products. The Company's main business scope include technology study and transfer of Chondroitin and Garlic Oil; trading, cold storage, and pretreating of Garlic, fruit, and vegetables products; trading of Chemical products (excluding hazardous chemicals); Import and export of goods and technology (excluding those restricted by government); the manufacturing and sale of health products including powder, granules, tablets, hard capsule, soft capsule products.

Product Overview

The Company’s main products can be divided into two groups, one is health food products and the other is hygienic products

Health Food Products

Phytocholesterol tabletting candy,

Phytosterol has strong anti-inflammatory effects to the human body, which can inhibit the absorption of cholesterol for human and biochemical synthesis of cholesterol. Promote the degradation and metabolism of cholesterol. Phytosterol can be used for prevention & therapy of coronary atherosclerosis heart disease. In treating ulcers, skin squamous carcinoma and cervical cancer has obvious curative effect. Can promote wound healing, make muscle proliferation, enhance capillary circulation; also can be used as blocking agent of formation of gallstones.

Polydextrose tabletting candy,

Regulating blood lipid, reduce fat accumulation preventing the fat.

Dunaliella salina haematococcus pluvialis tabletting candy,

Replenishing the body's astaxanthin, Natural carotene and variety of minerals, have a great effect of antioxidant activity, protect skin, protect vision and improve immunity.

Dunaliella salina Gum Base candy,

Dunaliella salina is rich in antioxidant needed by the human body health, resistance to radiation and enhance human immunity of natural carotenoids and 70 kinds of minerals and trace elements.

Haematococcus pluvialis Gum candy,

The main components of Haematococcus Pluvialis is astaxanthin. It has nine anti-aging effect: can be Anti-aging and protect the skin; Protect the eye health; helps to support the cardiovascular system, maintain a healthy joints and connective tissue; increases strength and endurance.

Fish Oil Gum candy,

Adjusting blood liquid, prevent blood clots, cerebral thrombosis, cerebral hemorrhage and stroke; prevent arthritis and alzheimer's disease, improve the memory and vision, control presbyopia.

Earthworm Protein tabletting candy,

Improve blood circulation, inhibiting platelet aggregation, reduce glucose concentrations, prevent blood clots, has the very good control efficiency for coronary heart disease, arteriosclerosis, and other hematologic disorders.

Collagen Protein tabletting candy,

It is rich in glycine, proline hydroxyproline and other amino acid needed for human body. Have a good health care effect for skin, hair, bones and muscles.

Krill Oil Gum candy,

It is rich in EPA and DHA. Enhancing health effects, including cardiovascular, nerve, bones, joints, vision, skin care, etc.

Phosphatidylserine tabletting candy,

Improve the function of brain; help to repair the injure of brain; promote the recovery of brainfag; protect central nervous system. Used for auxiliary treatment dementia and agedness memory loss.

Milk Powder tabletting candy.

Milk tablet is kind of leisure food. Supplement of the nutrition of human needed in specific environment.

Hygienic Products

The hygienic product line includes the following products:

Gel for women,

Anti-bacteria product. Auxiliary treatment bacterial, mould sex vaginitis.

Skin comfortable liquid

Anti-bacteria product. Used for sterilization, antibacterial of skin. Inhibit the bromhidrosis and relief beriberi itch.

Confucian owns 100,000 stage purification workshops, advanced production lines and manufacturing equipment. The Company has a higher capacity for OEM processing of tablets, hard capsules, soft capsules, oral liquid, granules, and powders.

Plan of Operations

By following the Company motto of "being passionate for health industry, bringing together the world's resources, focusing on consumer demand, creating a “win-win situation", the Company is eager to develop businesses in the international health and pharmaceutical market.

The Company’s near-term goal is to reach breakeven within a six-month period time. In order to reach such goal, the Company is increasing its sales and production volume through arrangements and networking with its existing customers and its affiliated companies. Additionally, it plans to increase the size of its sales department to develop new customers.

The Company’s ultimate goal is to make the business profitable and competitive in the international health and pharmaceutical market. To achieve such goal, the Company needs to cooperate with other businesses having capital, market, technology, or products, recruit sufficient workforce and various talents to serve the company, and actively develop new technology and new product through research and development.

Results of Operations

Three and Six Months Ending June 30, 2018 Compared to June 30, 2017

Revenue:

For the three months ended June 30, 2018 and 2017, revenues were $674,441 and $606,693 respectively, for an increase of $67,748 over the same period in 2017. For the six months ended June 30, 2018 and 2017, revenues were $935,621 and $886,534 respectively, for an increase of $49,087 over the same period in 2017. The sales in RMB were almost the same over the same period in 2017. The slight increase is mainly due to the exchange rate of Chinese RMB against US dollar increased over the same period in 2017.

For the three months ended June 30, 2018 and 2017, revenues to related parties were $461,039 and $105,566 respectively, an increase of $355,473. The revenue to related parties as a percent of revenue were 68% and 17%, an increase of 51%. For the six months ended June 30, 2018 and 2017, revenues to related parties were $589,651 and $150,875 respectively, an increase of $438,776. The revenue to related parties as a percent of revenue were 62% and 17%, an increase of 45%.

Cost of Goods Sold:

Cost of goods sold for the three months ended June 30, 2018 and 2017 were $478,897 and $562,699 respectively, for a decrease of $83,802 over the same period in 2017. Cost of goods sold for the six months ended June 30, 2018 and 2017 were $698,150 and $840,716 respectively, for a decrease of $142,566 over the same period in 2017. This decrease is mainly due to the decrease in cost of production compared to same periods in 2017.

Gross Profit:

Gross profit was $195,544 and $43,994 for the three months ended June 30, 2018 and 2017, an increase of $151,550 over the same period in 2017. The gross profit margin as a percent of sales for the three months ending June 30, 2018 and 2017 was 29% and 7% respectively.

Gross profit was $237,471 and $45,818 for the six months ended June 30, 2018 and 2017, an increase of $191,653 over the same period in 2017. The gross profit margin as a percent of sales for the six months ending June 30, 2018 and 2017 was 25% and 5% respectively.

The increase of gross profit was mainly due to the increase in domestic sales of new products, primarily sales to a related party, which maintained higher profit margin and to the improvements in production efficiency.

Operating Expenses:

Operating expenses for the three-month period ended June 30, 2018 and 2017 were $132,011 and $167,724 respectively for a decrease of $35,713 or 21% from the same period of prior year. The major expenses for the three-month period ended June 30, 2018 and 2017 consist of payroll, professional fees and tax. The decrease of $35,713 was mainly due to a decrease in payroll expense of $18,586 and decrease in professional fee of $27,958.

Operating expenses for the six-month period ended June 30, 2018 and 2017 were $279,101 and $357,123 respectively for a decrease of $78,022 or 22% from the same period of prior year. The major expenses for the six-month period ended June 30, 2018 and 2017 consist of payroll, professional fees and tax. The decrease of $78,022 was mainly due to a decrease in payroll expense of $31,992 and decrease in professional fee of $54,202.

Other Income:

Other income consists of interest income and expenses and other non-operation related income and expenses. Other income for the three months ended June 30, 2018 and 2017 were $16,091 and $61 respectively for an increase of $16,030 over the same period in 2017. For the six months ended June 30, 2018 and 2017, the other income were $11,060 and $3,066 respectively for an increase of $7,994 over the same period in 2017. The increase was mainly due to a government reward received during the second quarter of 2018 amounted to approximately $16,652.

Liquidity and Capital Resources

The Company suffered recurring losses from operations and has an accumulated deficit of $1,250,396 at June 30, 2018. The Company has a cash balance of $91,329 and a working capital deficit of $2,986,996 as of June 30, 2018. Net income and net losses for the three months ended June 30, 2018 and 2017 were $79,624 and $123,669, respectively. The Company has incurred losses of $30,570 and $308,239 for the six months ended June 30, 2018 and 2017, respectively. The Company has not continually generated significant revenues. Unless our operations continue to generate significant revenues and cash flows from operating activities, our continued operations will depend on whether we are able to raise additional funds through various sources, such as equity and debt financing, other collaborative agreements and strategic alliances. Our management is actively engaged in seeking additional capital to fund our operations in the short to medium term. Such additional funds may not become available on acceptable terms and there can be no assurance that any additional funding that we do obtain will be sufficient to meet our needs in the long term.

Net cash used in operating activities for the six months ended June 30, 2018 amounted to $283,065, compared to $252,501 used in operating activities for the six months ended June 30, 2017. The increase of $30,564 in the net cash used in our operating activities was primarily due to the increase in the change of accounts receivable of $13,554, increase in the change of accounts receivable-related party of $189,573, increase in the change other receivable of $70,198, increase in the change of inventory of $200,379, and decrease in change of accounts payable-related of $71,272; partially offset by the decrease in net loss of $277,669 from operations, increase in change of accounts payable of $38,951, increase in the change of customer deposit of $175,368, and increase in the change of customer deposit-related party of $34,736.

Net cash used in investing activities for the six months ended June 30, 2018 amounted at $97,576 compared to net cash used in investing activities of $8,441 for the six months ended June 30, 2017, resulting in an increase of $89,135. The increase was mainly due to increase in deferred cost for six months ended June 30, 2018 by $14,946, and increase in construction in process for six months ended June 30, 2018 by $78,548; partially offset by decrease of purchase of property and equipment by $4,359.

Net cash provided by financing activities for the six months ended June 30, 2018 amounted at $97,667, compared to net cash used in financing activities of $50,894 in the six months ended June 30, 2017, resulting in a net increase of $148,561. The increase in net cash provided by financing activities was mainly due to increase of change of advances received from related party and partially offset by decrease in change of loan payable from unrelated party.

Going Concern

Capital Resources

Over the next twelve months, management believes there will not be sufficient working capital obtained from operations due to the Company in its early development stage.

Off-Balance Sheet Arrangements

As of June 30, 2018, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.

ITEM 3.

Quantitative and Qualitative Disclosures about Mark Risk

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, the Company is not required to provide the information required by this Item

ITEM 4.

Controls and Procedures.

Evaluation of Disclosure Controls and Procedures:

As of June 30, 2018, we conducted an evaluation under the supervision and with the participation of the Company's Chief Executive Officer and the Chief Financial Officer, management has evaluated the effectiveness of the design and operation of the Company's disclosure controls and procedures. Based on that evaluation and because of the material weaknesses in our internal control over financial reporting described below, the Chief Executive Officer and the Chief Financial Officer have concluded that the Company's disclosure controls and procedures were not effective as of June 30, 2018.

Management identified the following control deficiencies that constitute material weaknesses that are not fully remediated as of the filing date of this report:

Our size has prevented us from being able to employ sufficient resources to enable us to have an adequate level of supervision and segregation of duties within our internal control system. There is mainly one person involved in processing of transactions. Therefore, it is difficult to effectively segregate accounting duties. We have hired an additional administrative person and retained an outside professional firm to assist in mitigating the separation of duties issues on an ongoing basis. The use of the outside firm has proven successful in assisting in the separation of duties. However, additional people are not needed to do the administrative work therefore segregation of duties will continue to be an ongoing weakness.

Similarly, the Shandong Confucian Biologic Co., Ltd. operation also has a material weakness due to lack of segregation of duties. Its size has prevented us from being able to employ sufficient resources to enable us to have an adequate level of supervision and segregation of duties within our internal control system. We have retained an outside professional firm to assist in the separation of duties on an ongoing basis. The use of the outside firm has proven successful in assisting in the separation of duties.

Limitations on the Effectiveness of Internal Controls

Disclosure controls and procedures, no matter how well designed and implemented, can provide only reasonable assurance of achieving an entity's disclosure objectives. The likelihood of achieving such objectives is affected by limitations inherent in disclosure controls and procedures. These include the fact that human judgment in decision-making can be faulty and that breakdowns in internal control can occur because of human failures such as simple errors or mistakes or intentional circumvention of the established process.

Changes in Internal Control over Financial Reporting

There were no changes in internal control over financial reporting that occurred during the current quarter covered by this report that have materially affected, or are reasonably likely to affect, the Company's internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1.

Legal Proceedings

None

ITEM 1A.

Risk Factors

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, the Company is not required to provide the information required by this Item.

ITEM 2.

Unregistered Sales of Equity Securities and Use of Proceeds

None

ITEM 3.

Defaults Upon Senior Securities

Not Applicable

ITEM 4.

Mine Safety Disclosures

None

ITEM 5.

Other Information

None

ITEM 6.

Exhibits

a) Exhibits

	2.1	Share Exchange Agreement among IPLO, Yibaoccyb and Xiuhua Song dated July 1, 2016 (Incorporated by reference to Exhibit 2.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on July 11, 2016.)
	10.1	Stock Purchase Agreement between IPLO and Xiuhua Song dated May 15, 2016. (Incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on July 11, 2016.)
	10.2	Stock Purchase Agreement among IPLO, Standard Resources Ltd., and H&H Glass Inc. dated July 1, 2016. (Incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on July 11, 2016.)
	10.3	Consulting Services Agreement between YibaoHK and Shandong Confucian Biologics Co. Ltd. dated August 31, 2016 (Incorporated by reference to Exhibit 99.6 to the Current Report on Form 8-K/A filed with the Securities and Exchange Commission on September 6, 2016.)
	10.4	Equity Pledge Agreement between YibaoHK, Shandong Confucian Biologics Co. Ltd. and the owners of Shandong Confucian Biologics Co. Ltd. dated August 31, 2016 (Incorporated by reference to Exhibit 99.7 to the Current Report on Form 8-K/A filed with the Securities and Exchange Commission on September 6, 2016.)
	10.5	Operating Agreement between YibaoHK, Shandong Confucian Biologics Co. Ltd. and the owners of Shandong Confucian Biologics Co. Ltd. dated August 31, 2016 (Incorporated by reference to Exhibit 99.8 to the Current Report on Form 8-K/A filed with the Securities and Exchange Commission on September 6, 2016.)
	10.6	Voting Rights and Proxy Agreement between YibaoHK, Shandong Confucian Biologics Co. Ltd. and the owners of Shandong Confucian Biologics Co. Ltd. dated August 31, 2016 (Incorporated by reference to Exhibit 99.9 to the Current Report on Form 8-K/A filed with the Securities and Exchange Commission on September 6, 2016.)
	10.7	Option Agreement between YibaoHK, Shandong Confucian Biologics Co. Ltd. and the owners of Shandong Confucian Biologics Co. Ltd. dated August 31, 2016 (Incorporated by reference to Exhibit 99.10 to the Current Report on Form 8-K/A filed with the Securities and Exchange Commission on September 6, 2016.)
	31.1	Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) (Section 302 of the Sarbanes-Oxley Act of 2002)
	31.2	Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) (Section 302 of the Sarbanes-Oxley Act of 2002)
	32.1	Certification of the Chief Executive Officer pursuant to 18 U.S.C.ss.1350 (Section 906 of the Sarbanes-Oxley Act of 2002)
	32.2	Certification of the Chief Financial Officer pursuant to 18 U.S.C.ss.1350 (Section 906 of the Sarbanes-Oxley Act of 2002)
	101.INS	XBRL Instance Document
	101.SCH	XBRL Schema Document
	101.CAL	XBRL Calculation Linkbase Document
	101.DEF	XBRL Definition Linkbase Document
	101.LAB	XBRL Label Linkbase Document
	101.PRE	XBRL Presentation Linkbase Document

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		YBCC, INC.
		(Registrant)


Dated: August 15, 2018	By:	/s/ Xiuhua song
		Xiuhua Song
		Chief Executive Officer
		Principal Financial Officer and Director

EX-31.1 2 ybcc_10q-ex3101.htm CERTIFICATION

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO

SECURITIES EXCHANGE ACT RULES 13A-14 AND 15D-14

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Xiuhua Song, certify that:

1. I have reviewed this quarterly report on Form 10-Q of YBCC, Inc. (the "Company");

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this report;

4. The small business issuer's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the small business issuer and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the small business issuer's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any changes in the small business issuer's internal control over financial reporting that occurred during the small business issuer's most recent fiscal quarter (the small business issuer's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the small business issuer's internal control over financial reporting; and

5. The small business issuer's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the small business issuer's auditors and the audit committee of small business issuer's board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuer's ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuer's internal control over financial reporting

Dated: August 15, 2018

/s/ Xiuhua Song

Xiuhua Song

Chief Executive Officer and Director

EX-31.2 3 ybcc_10q-ex3102.htm CERTIFICATION

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO

SECURITIES EXCHANGE ACT RULES 13A-14 AND 15D-14

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Xiuhua Song, certify that:

1. I have reviewed this quarterly report on Form 10-Q of YBCC, Inc., (the "Company");

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuer's internal control over financial reporting

Dated: August 15, 2018

/s/ Xiuhua Song

Xiuhua Song

Chief Financial Officer

EX-32.1 4 ybcc_10q-ex3201.htm CERTIFICATION

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of YBCC, Inc. (the "Company") on Form 10-Q for the period ending June 30, 2018 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Xiuhua Song, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that, to the best of the undersigned’s knowledge and belief:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/ Xiuhua Song

Xiuhua Song

Chief Executive Officer, and Director

Dated: August 15, 2018

EX-32.2 5 ybcc_10q-ex3202.htm CERTIFICATION

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of YBCC, Inc. (the "Company") on Form 10-Q for the period ending June 30, 2018 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Xiuhua Song, Chief Finanial Officer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that, to the best of the undersigned’s knowledge and belief:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/ Xiuhua Song

Xiuhua Song

Chief Financial Officer

Dated: August 15, 2018

GRAPHIC 6 image_001.jpg GRAPHIC begin 644 image_001.jpg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ybao-20180630.xml XBRL INSTANCE FILE 0000822997 2017-01-01 2017-12-31 0000822997 2016-12-31 0000822997 2017-12-31 0000822997 2018-08-14 0000822997 us-gaap:BuildingMember 2018-01-01 2018-06-30 0000822997 us-gaap:OfficeEquipmentMember 2018-01-01 2018-06-30 0000822997 us-gaap:EquipmentMember 2018-01-01 2018-06-30 0000822997 currency:CNY YBAO:BalanceSheetMember 2017-12-31 0000822997 YBAO:YibaccybMember 2018-01-01 2018-06-30 0000822997 YBAO:YibaoccbyMember 2018-06-30 0000822997 YBAO:YibaoHKMember 2018-01-01 2018-06-30 0000822997 YBAO:ShandongConfucianMember 2018-01-01 2018-06-30 0000822997 country:CN 2018-06-30 0000822997 country:CN 2017-12-31 0000822997 YBAO:VATMember 2017-12-31 0000822997 YBAO:PrepaidProfessionalFeesMember 2017-12-31 0000822997 YBAO:PrepaidProfessionalFeesMember 2018-06-30 0000822997 us-gaap:BuildingMember 2017-12-31 0000822997 us-gaap:VehiclesMember 2017-12-31 0000822997 us-gaap:EquipmentMember 2017-12-31 0000822997 us-gaap:OfficeEquipmentMember 2017-12-31 0000822997 YBAO:Land1Member 2017-12-31 0000822997 YBAO:Land1Member 2018-06-30 0000822997 YBAO:Land2Member 2017-12-31 0000822997 YBAO:Land2Member 2018-06-30 0000822997 YBAO:Land3Member 2017-12-31 0000822997 YBAO:Land3Member 2018-06-30 0000822997 YBAO:ShandongYibaoMember 2017-12-31 0000822997 YBAO:ShandongYibaoMember 2018-06-30 0000822997 YBAO:SongMember 2017-12-31 0000822997 YBAO:SongMember 2018-06-30 0000822997 YBAO:HengchunZhangMember 2017-12-31 0000822997 YBAO:HengchunZhangMember 2018-06-30 0000822997 currency:CNY YBAO:BalanceSheetMember 2018-06-30 0000822997 YBAO:YibaoHKMember 2018-06-30 0000822997 YBAO:ShandongConfucianMember 2018-06-30 0000822997 2018-06-30 0000822997 2018-01-01 2018-06-30 0000822997 2017-01-01 2017-06-30 0000822997 2017-06-30 0000822997 country:US 2018-06-30 0000822997 country:US 2017-12-31 0000822997 YBAO:SevenInvestorsMember 2017-01-01 2017-12-31 0000822997 YBAO:ShandongYibaoMember 2017-01-01 2017-06-30 0000822997 YBAO:ShandongYibaoMember 2018-01-01 2018-06-30 0000822997 YBAO:SuppliesMember YBAO:Supplier1Member 2018-01-01 2018-06-30 0000822997 us-gaap:SalesRevenueNetMember YBAO:AnhuiMember 2018-01-01 2018-06-30 0000822997 us-gaap:SalesRevenueNetMember YBAO:PingXiangMember 2018-01-01 2018-06-30 0000822997 us-gaap:SalesRevenueNetMember YBAO:ShandongYibaoBiologicsMember 2018-01-01 2018-06-30 0000822997 us-gaap:BuildingMember 2018-06-30 0000822997 us-gaap:VehiclesMember 2018-06-30 0000822997 us-gaap:EquipmentMember 2018-06-30 0000822997 us-gaap:OfficeEquipmentMember 2018-06-30 0000822997 us-gaap:SalesRevenueNetMember YBAO:PingXiangMember 2017-01-01 2017-06-30 0000822997 currency:CNY YBAO:IncomeStatementMember 2018-01-01 2018-06-30 0000822997 currency:CNY YBAO:IncomeStatementMember 2017-01-01 2017-06-30 0000822997 YBAO:VATMember 2018-06-30 0000822997 us-gaap:SeriesBPreferredStockMember 2018-06-30 0000822997 us-gaap:SeriesBPreferredStockMember 2017-12-31 0000822997 YBAO:SuppliesMember YBAO:SupplierAMember 2017-01-01 2017-06-30 0000822997 YBAO:UtilitiesMember 2018-06-30 0000822997 YBAO:UtilitiesMember 2017-12-31 0000822997 YBAO:OtherPrepaidExpensesMember 2018-06-30 0000822997 YBAO:OtherPrepaidExpensesMember 2017-12-31 0000822997 YBAO:UsaMember 2018-06-30 0000822997 YBAO:ChinaMember 2018-06-30 0000822997 YBAO:UsaMember 2017-06-30 0000822997 YBAO:ChinaMember 2017-06-30 0000822997 YBAO:TemporaryDifferencesMember 2018-06-30 0000822997 YBAO:TemporaryDifferencesMember 2017-12-31 0000822997 YBAO:SuppliesMember YBAO:SupplierBMember 2017-01-01 2017-06-30 0000822997 us-gaap:SalesRevenueNetMember YBAO:NanjingHejianMember 2017-01-01 2017-06-30 0000822997 us-gaap:SalesRevenueNetMember YBAO:ShandongYibaoBiologicsMember 2017-01-01 2017-06-30 0000822997 2018-04-01 2018-06-30 0000822997 2017-04-01 2017-06-30 0000822997 currency:CNY YBAO:IncomeStatementMember 2018-04-01 2018-06-30 0000822997 currency:CNY YBAO:IncomeStatementMember 2017-04-01 2017-06-30 0000822997 YBAO:ShandongImportMember 2018-01-01 2018-06-30 0000822997 YBAO:ShandongImportMember 2017-01-01 2017-06-30 0000822997 YBAO:SuppliesMember YBAO:SupplierCMember 2017-01-01 2017-06-30 0000822997 us-gaap:SalesRevenueNetMember YBAO:JiangshanMember 2017-01-01 2017-06-30 0000822997 YBAO:TemporaryFundingMember 2018-06-30 0000822997 YBAO:TemporaryFundingMember 2017-12-31 0000822997 us-gaap:ConstructionInProgressMember 2018-06-30 0000822997 us-gaap:ConstructionInProgressMember 2017-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure YBAO:RMB

.2296

.2630

.1235

.5412

.2265

.3116

.2383

.1598

.1190

.1543

.2001

559327

660738

3097907

1858989

11912

1133045

93961

3139985

1825466

11712

1132377

92474

77956

50000000

0.0001

900000000

0.001

9894214

974730

50753

44974

38274

39785

1511

1537

4242

5814

33251

86989

17353

69636

127335

373860

600953

853365

9894214

304291

292072

325777

7106

14502

46902

225671

26035

37175

P20Y

P5Y

P10Y

6.51

6.62

.51

1.0

BVI Company Hong Kong Company China Operating Company

786075

553332

544066

207491

204017

25252

24830

772913

60032

66756

3000000

47292

96512

23626

-20484

37893

18256

330451

327310

23626

-20484

37893

18256

330451

327310

0.34

.21

-.34

-.21

0.25

-.25

-0.25

0.00

19319

-6444

113771

YBCC, Inc. 0000822997 10-Q 2018-06-30 false --12-31 No No Yes Smaller Reporting Company Q2 2018

115126

98708

57623

49794

8035

7443

4010

3729

9693

-148426

6126

589651

150875

105476

589651

45399

6.37 6.87 6.38 6.86

2538580

2479247

726043

706157

6052

6005

3871628

4044774

3623493

3840361

313806

244475

92122

101286

31314

213628

124714

140098

160625

187924

3623493

3840361

3871628

4044774

248135

204413

-43937

-121364

-1179676

-1250396

-36581

-43288

1162328

9894

9894214

9861065

9894214

9891214

-0.00

-0.03

0.01

-0.01

-13152

13716

-24249

8315

-31538

40149

-48905

60488

-13077

-30570

-308239

79624

-123669

-30570

-308239

79624

-123669

133

102

133

10927

2964

15958

-6

-41630

-311305

63533

-123730

279101

357123

132011

167724

268853

344001

124843

162604

10248

13122

7168

5120

237471

45818

195544

43994

300000

339147

369607

53213

307361

91329

27768

38116

62246

-278278

-311379

4696

460

19028

23387

14946

-66609

-62270

11130

14431

0 -34736

190065

14697

15639

12773

31173

3194

146

258486

58107

-10871

-6882

55668

37957

58154

-12044

189573

6044

-7510

-283065

-252501

-97576

-8441

97667

-50894

20007

73223

.25

6126

182365

935621

886534

674441

606693

698150

840716

478897

562699

-70719

-259335

19136

-110593

-30834

-301244

73701

-119428

-6444

6721

-11882

4074

-37278

-294523

61819

-115354

87974

97532

188179

-88781

11060

3066

16091

71272

78548

Impairment of Long-Live Assets – The Company applies FASB ASC 360, “Property, Plant and Equipment,” which addresses the financial accounting and reporting for the recognition and measurement of impairment losses for long-lived assets. In accordance with ASC 360, long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company will recognize the impairment of long-lived assets in the event the net book value of such assets exceeds the future undiscounted cash flows attributable to those assets. There is no impairment of our long-lived assets for the six months ended June 30, 2018 and 2017.

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="width: 75%; text-align: justify">Balance sheet</td> <td style="width: 25%; text-align: justify"> </td></tr> <tr> <td style="vertical-align: bottom; text-align: justify">Balance sheet as of June 30, 2018</td> <td style="text-align: right">RMB 6.62 to US $1.00</td></tr> <tr> <td style="vertical-align: bottom">Balance sheet as of December 31, 2017</td> <td style="text-align: right">RMB 6.51 to US $1.00</td></tr> <tr> <td style="vertical-align: bottom"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">Statement of operation and other comprehensive income</td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">Statement of operation and other comprehensive income for three months ended June 30, 2018</td> <td style="text-align: right">RMB 6.38 to US $1.00</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">Statement of operation and other comprehensive income for three months ended June 30, 2017</td> <td style="text-align: right">RMB 6.86 to US $1.00</td></tr> <tr style="vertical-align: bottom"> <td>Statement of operation and other comprehensive income for six months ended June 30, 2018</td> <td style="text-align: right">RMB 6.37 to US $1.00</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">Statement of operation and other comprehensive income for six months ended June 30, 2017</td> <td style="text-align: right">RMB 6.87 to US $1.00</td></tr> </table> <table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; width: 75%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 25%; text-align: center">Category</td> <td style="width: 25%; text-align: center">Estimated Life</td> <td style="width: 25%; text-align: center">Method</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">Manufacturing equipment </td> <td style="text-align: center">10</td> <td style="text-align: center">Straight Line</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">Office equipment</td> <td style="text-align: center">5</td> <td style="text-align: center">Straight Line</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">Buildings</td> <td style="text-align: center">20</td> <td style="text-align: center">Straight Line</td></tr> </table>

Fair Value of Financial Instruments – FASB ASC 820, “Fair Value Measurement” specifies a hierarchy of valuation techniques based upon whether the inputs to those valuation techniques reflect assumptions other market participants would use based upon market data obtained from independent sources (observable inputs). In accordance with ASC 820, the following summarizes the fair value hierarchy:   Level 1 Inputs— Unadjusted quoted market prices for identical assets and liabilities in an active market that the Company has the ability to access.   Level 2 Inputs— Inputs other than the quoted prices in active markets that are observable either directly or indirectly.   Level 3 Inputs— Inputs based on valuation techniques that are both unobservable and significant to the overall fair value measurements   ASC 820 requires the use of observable market data, when available, in making fair value measurements. When inputs used to measure, fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.   The Company did not identify any assets or liabilities that are required to be presented at fair value on a recurring basis. Carrying values of non-derivative financial instruments, including cash and cash equivalents, accounts receivable, inventories, prepaid expenses, advances from customers, accounts payable, taxes payable, accrued liabilities and other payables, and loan from bank, approximated their fair values due to the short maturity of these financial instruments. There were no changes in methods or assumptions during the periods presented.

NOTe 5 - prepaid expenses   Prepaid expenses were comprised of the following:   <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">June 30, 2018</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">December 31, 2017</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 45%">Utilities</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,511</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,537</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Professional fees</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">38,274</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">44,974</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4,242</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">39,785</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">50,753</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid">The land use right term</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">June 30, 2018</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">December 31, 2017</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 45%; text-align: left">May, 2013 - Apr. 2063</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">544,066</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">553,332</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Dec. 2015 - Sept. 2065</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">204,017</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">207,491</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Dec. 2015 – Sept. 2065</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">24,830</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">25,252</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Intangible assets- total</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">772,913</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">786,075</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Less: accumulated amortization</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(66,756</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(60,032</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Intangible assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">706,157</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">726,043</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Amount</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 45%; text-align: left; padding-bottom: 1pt">2018 calendar year</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</td><td style="width: 11%; border-bottom: Black 1pt solid; text-align: right">6,126</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,126</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

NOTE 11 - NON-CONTROLLING INTEREST   On July 1, 2016, the Company executed the Exchange Agreement with Yibaoccyb and the Yibaoccyb Shareholders. From and after the Closing Date, Yibaoccyb became a 51% owned subsidiary of the Company. Yibaoccyb owns 100% of YibaoHK. YibaoHK will own 100% of Shenzhen Confucian Biologics Co. Ltd. (yet to be formed, “Yibao WFOE”), which will be wholly foreign-owned enterprise (“WFOE”) under the laws of the Peoples’ Republic of China (“PRC” or “China”). On August 31, 2016, YibaoHK entered into a series of contractual arrangements with Confucian and currently is 100% owner of Confucian.   Non-controlling interest consisted of the following:    <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 85%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center">June 30,</td><td> </td><td> </td> <td colspan="2" style="text-align: center">December 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2018</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2017</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 55%; text-align: left">Beginning balance</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">292,072</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">304,291</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net income (loss) attributed to non-controlling interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">40,149</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(31,538</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt">Foreign currency translation gain (loss) attributable to non-controlling interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(6,444</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">19,319</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Ending balance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">325,777</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">292,072</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 41%; border-bottom: black 1pt solid">Name of Entity or Individual</td> <td style="white-space: nowrap; width: 3%"> </td> <td style="white-space: nowrap; width: 56%; border-bottom: black 1pt solid"> Relationship with the Company and subsidiaries </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="white-space: nowrap">Shandong Yibao Biologics Co, Ltd</td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap">Affiliated company with common shareholders</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td colspan="2" style="white-space: nowrap">Shandong Yibao Import & Export Trading Co, Ltd </td> <td style="white-space: nowrap">Affiliated company with common shareholders</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="white-space: nowrap">Ms. Xiuhua Song</td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap">Director and controlling beneficiary shareholder of the Company </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap">Mr. Hengchun Zhang</td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap">Owner of Shandong Confucian Biologics </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="white-space: nowrap">Mr. Qingbao Kong</td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap">Ms. Xiuhua Song’s spouse</td></tr> </table>

.49

P50Y

2900912

2630912

2602842

270000

265479

2868321

84629

2900912

2868321

NOTE 1 - ORGANIZATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES   Organization and Operations – YBCC, Inc., (The “Company” or “YBAO”), formerly known as International Packaging and Logistic Group, Inc., a Nevada corporation, was originally incorporated on June 2, 1986, in the state of Delaware. On April 17, 2008, the Company redomiciled form the State of Delaware to the State of Nevada.   On July 2, 2007, the Company through its wholly-owned subsidiary, YesRx.com (“YesRx”) acquired all the outstanding shares of H&H Glass, Inc. (“H&H Glass”), in exchange for 3,915,000 shares of its common stock in a reverse triangular merger.   On May 15, 2016, the Company and Xiuhua Song (the “Purchaser”) entered into a Stock Purchase Agreement (the “Purchase Agreement”), pursuant to which IPLO (the “Seller”) would sell to the Purchaser, and the Purchaser will purchase from the Seller, an aggregate of 3,915,000 newly issued shares of IPLO Common Stock (the “Shares”), which Shares represented 87% of the issued and outstanding shares of common stock. On July 1, 2016, this transaction was completed.   On July 1, 2016, Standard Resources Ltd. (“Standard”), previously IPLO’s majority stockholder, and IPLO entered into a share purchase agreement (“H&H Vend Out”) whereby Standard would cancel 3,915,000 shares of IPLO common stock held by it in exchange for all of the outstanding shares of H&H Glass. The H&H Glass Vend Out was completed on August 31, 2016.   On July 1, 2016, the Company executed a Share Exchange Agreement (“Exchange Agreement”) by and among Yibaoccyb Limited, a British Virgin Islands limited liability company (“Yibaoccyb”), and the stockholders of 51% of Yibaoccyb’s common stock (the “Yibaoccyb Shareholders”), on the one hand, and the Company, on the other hand. Yibaoccyb owns 100% of YibaoConfucian Co., Ltd. (“YibaoHK”), a Hong Kong company. YibaoHK will own 100% of Shenzhen Confucian Biologics Co. Ltd. (yet to be formed, “Yibao”), which will be a wholly foreign-owned enterprise (“WFOE”) under the laws of the Peoples’ Republic of China (“PRC” or “China”). On August 31, 2016, YibaoHK entered into a series of contractual arrangements with Shandong Confucian Biologics Co., Ltd. (“Confucian”) which is a limited liability company headquartered in, and organized under the laws of, the PRC. The contractual arrangements are discussed below.   The Exchange Agreement was completed on August 31, 2016 concurrent with the H&H Vend Out. The Company issued 2,040,000 shares of the Company’s common stock (the “IPLO Shares”) to the Yibaoccyb Shareholders in exchange for 51% of the common stock of Yibaoccyb.   On December 22, 2016, the Company amended its Certificate of Incorporation (the “Amendment”). As a result of the Amendment, the Company’s corporate name was changed from International Packaging and Logistics Group, Inc. to YBCC, Inc.   Yibaoccyb is a limited liability company incorporated under the laws of the British Virgin Islands on May 30, 2016. Other than all the issued and outstanding shares of YibaoHK, Yibaoccyb has no other assets or operations.   YibaoHK is a limited liability company incorporated under the laws of the Hong Kong on June 15, 2016, which was formed by Yibaoccyb.   Confucian was founded on October 31, 2012. Confucian is in the Food Industrial Park inside the economic development Zone of JinXiang County, Jining City in the province of Shandong in China.   Confucian possesses manufacturing permits for food product, hygienic products, sanitary products, and health products. The Company's main business includes research and development of chondroitin and garlic oil; trading, cold storage, and pretreating of garlic, fruit, and vegetables products; trading of chemical products (excluding hazardous chemicals); import and export of goods and technology (excluding those restricted by China government); and, the manufacturing and sale of health products including powder, granules, tablets, hard capsule, soft capsule products.   Details of the Company’s structure as of June 30, 2018 is as follow:   Reverse Merger Accounting – Since YBCC and Yibaoccyb were entities under Ms. Song’s common control prior to the share exchange, the transaction was accounted for as a restructuring transaction in accordance with generally accepted accounting principles in the United States ("GAAP"). YBCC has recast prior period unaudited consolidated financial statements to reflect the conveyance of Yibaoccyb’s common shares as if the restructuring transaction had occurred as of the earliest date of the unaudited consolidated financial statements.   Basis of Presentation - The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and note disclosures required by U.S. generally accepted accounting principles (“U.S. GAAP”) for complete audited financial statements. The accompanying unaudited financial information should be read in conjunction with the audited consolidated financial statements, including the notes thereto, as of and for the year ended December 31, 2017, included in our 2017 Annual Report on Form 10-K filed with the SEC. The information furnished in this report reflects all adjustments (consisting of normal recurring adjustments), which are, in the opinion of management, necessary for a fair presentation of our financial position, results of operations and cash flows for each period presented. The results of operations for the six months ended June 30, 2018 are not necessarily indicative of the results for the year ending December 31, 2018 or for any future period.    Principles of Consolidation - The unaudited condensed consolidated financial statements include the accounts of YBCC and its subsidiaries. The Company’s subsidiaries include 51% of Yibaoccyb, YibaoHK and Confucian, of which 49% of Yibaoccyb’s consolidated operating results was shown in non-controlling interest on the consolidated balance sheets.   Intercompany accounts and transactions have been eliminated upon consolidation.   Use of Estimates - The preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimate and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. The most significant estimates reflected in the condensed consolidated financial statements include allowance for doubtful accounts, allowance for inventory, depreciation, useful lives of property and equipment, deferred income taxes, useful life of intangible assets, and contingencies. Estimates and assumptions are periodically reviewed and the effects of revisions are reflected in the unaudited condensed consolidated financial statements in the period they are determined to be necessary.   Inventories - Inventory is valued at the lower of cost or market. Cost is determined using first-in, first-out method.   Inventory, comprised principally of finished goods, raw material and packaging material, are valued at the lower of cost or market.   <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">June 30, 2018</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">December 31, 2017</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 45%; text-align: left">Finished goods</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">14,502</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">7,106</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Work in progress</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">96,512</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">47,292</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Raw materials</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">225,671</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46,902</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Packaging material</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">37,175</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">26,035</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt; padding-left: 10pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">373,860</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">127,335</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>    The Company periodically estimates an inventory allowance for estimated unmarketable inventories. Inventory amounts are reported net of such allowances, if any. There were no allowances for inventory as of June 30, 2018 and December 31, 2017.   Revenue Recognition - The Company recognizes product revenue in accordance with ASC 606  . The core principle of ASC 606 is that an entity should recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve the core principle of ASC 606, an entity should take the following actions: Step 1: Identify the contract with a customer; Step 2: Identify the performance obligations in the contract; Step 3: Determine the transaction price; Step 4: Allocate the transaction price; Step 5: Recognize revenue when or as the entity satisfies a performance obligation. The Company complies with ASC 606 revenue recognition and follows the five-step revenue recognition model along with other guidance impacted by this standard.    Impairment of Long-Live Assets – The Company applies FASB ASC 360, “Property, Plant and Equipment,” which addresses the financial accounting and reporting for the recognition and measurement of impairment losses for long-lived assets. In accordance with ASC 360, long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company will recognize the impairment of long-lived assets in the event the net book value of such assets exceeds the future undiscounted cash flows attributable to those assets. There is no impairment of our long-lived assets for the six months ended June 30, 2018 and 2017.   Foreign Currency Translation - The Company's functional currency is the Chinese Renminbi (RMB). The reporting currency is that of the US Dollar. Assets, liabilities and owners’ contribution are translated at the exchange rates as of the balance sheet date. Income and expenditures are translated at the average exchange rate of the year. The RMB is not freely convertible into foreign currency and all foreign currency exchange transactions must take place through authorized institutions. No representation is made that the RMB amounts could have been, or could be, converted into US dollar at the rates used in translation.   The exchange rates used to translate amounts in RMB into USD for the purposes of preparing the financial statements were as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="width: 75%; text-align: justify">Balance sheet</td> <td style="width: 25%; text-align: justify"> </td></tr> <tr style="background-color: rgb(238,238,238)"> <td style="vertical-align: bottom; text-align: justify">Balance sheet as of June 30, 2018</td> <td style="text-align: right">RMB 6.62 to US $1.00</td></tr> <tr style="background-color: White"> <td style="vertical-align: bottom">Balance sheet as of December 31, 2017</td> <td style="text-align: right">RMB 6.51 to US $1.00</td></tr> <tr style="background-color: rgb(238,238,238)"> <td style="vertical-align: bottom"> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Statement of operation and other comprehensive income</td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Statement of operation and other comprehensive income for three months ended June 30, 2018</td> <td style="text-align: right">RMB 6.38 to US $1.00</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Statement of operation and other comprehensive income for three months ended June 30, 2017</td> <td style="text-align: right">RMB 6.86 to US $1.00</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Statement of operation and other comprehensive income for six months ended June 30, 2018</td> <td style="text-align: right">RMB 6.37 to US $1.00</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Statement of operation and other comprehensive income for six months ended June 30, 2017</td> <td style="text-align: right">RMB 6.87 to US $1.00</td></tr> </table>   Fair Value of Financial Instruments – FASB ASC 820, “Fair Value Measurement” specifies a hierarchy of valuation techniques based upon whether the inputs to those valuation techniques reflect assumptions other market participants would use based upon market data obtained from independent sources (observable inputs). In accordance with ASC 820, the following summarizes the fair value hierarchy:   Level 1 Inputs— Unadjusted quoted market prices for identical assets and liabilities in an active market that the Company has the ability to access.   Level 2 Inputs— Inputs other than the quoted prices in active markets that are observable either directly or indirectly.   Level 3 Inputs— Inputs based on valuation techniques that are both unobservable and significant to the overall fair value measurements   ASC 820 requires the use of observable market data, when available, in making fair value measurements. When inputs used to measure, fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.   The Company did not identify any assets or liabilities that are required to be presented at fair value on a recurring basis. Carrying values of non-derivative financial instruments, including cash and cash equivalents, accounts receivable, inventories, prepaid expenses, advances from customers, accounts payable, taxes payable, accrued liabilities and other payables, and loan from bank, approximated their fair values due to the short maturity of these financial instruments. There were no changes in methods or assumptions during the periods presented.   Net Earnings (Loss) Per Share – Earnings/(loss) per common share is computed on the weighted average number of common shares outstanding during each year. Basic earnings per share is computed as net loss applicable to common stockholders divided by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflects the potential dilution that could occur from common shares issuable through convertible preferred shares, stock options, warrants and other convertible securities when the effect would be dilutive. In this case, the Preferred Shares would not be dilutive since the conversion price is $3.00 and the quoted price is significantly lower than the conversion price. Therefore, there were no dilutive securities for the six months ended June 30, 2018 and 2017, respectively.   Reclassifications – Certain classifications have been made to the prior year consolidated financial statements to conform to the current year presentation. The reclassification had no impact on previously reported net loss or accumulated deficit.   Recent Accounting Pronouncements    In May 2014, the FASB issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers (Topic 606),” (“ASU 2014-09”). ASU 2014-09 supersedes the revenue recognition requirements in ASC 605 - Revenue Recognition (“ASC 605”) and most industry-specific guidance throughout ASC 605. The FASB has issued numerous updates that provide clarification on a number of specific issues as well as requiring additional disclosures. The core principle of ASC 606 requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. ASC 606 defines a five-step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing U.S. GAAP including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The guidance also requires enhanced disclosures regarding the nature, amount, timing and uncertainty of revenue and cash flows arising from an entity’s contracts with customers. The guidance may be adopted through either retrospective application to all periods presented in the financial statements (full retrospective approach) or through a cumulative effect adjustment to retained earnings at the effective date (modified retrospective approach). The Company had evaluated the effected that will result from adopting the guidance in this standard and concluded that the new revenue standards are not expected to have a material impact on the amount and timing of revenue recognized in the Company’s consolidated financial statements.   In November 2016, the FASB issued ASU 2016-18, “Statement of Cash Flows (Topic 230): Restricted Cash”. These amendments require that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. As a result, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The amendments do not provide a definition of restricted cash or restricted cash equivalents. The amendments in this ASU are effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted. The amendments should be applied using a retrospective transition method to each period presented. The Company has evaluated the impact of adopting ASU 2016-18 noting it will only impact the Company to the extent it has restricted cash in the future.   In July 2017, the FASB issued ASU 2017-11, Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception. For public business entities, the amendments in Part I of this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. For all other entities, the amendments in Part I of this Update are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted for all entities, including adoption in an interim period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. The amendments in Part II of this Update do not require any transition guidance because those amendments do not have an accounting effect. The Company is currently in the process of evaluating the impact of the adoption on its consolidated financial statements.   In February 2018, the FASB issued ASU No. 2018-02 Income Statement—Reporting Comprehensive Income (Topic 220)—Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. The amendments in this Update allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act of 2017. The amendments in this Update affect any entity that is required to apply the provisions of Topic 220, Income Statement-Reporting Comprehensive Income, and has items of other comprehensive income for which the related tax effects are presented in other comprehensive income as required by GAAP. The Company is currently in the process of evaluating the impact of the adoption on its consolidated financial statements.   The Company has considered all new accounting pronouncements and has concluded that there are no new pronouncements that may have a material impact on results of operations, financial condition, or cash flows, based on current information.

Recent Accounting Pronouncements    In May 2014, the FASB issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers (Topic 606),” (“ASU 2014-09”). ASU 2014-09 supersedes the revenue recognition requirements in ASC 605 - Revenue Recognition (“ASC 605”) and most industry-specific guidance throughout ASC 605. The FASB has issued numerous updates that provide clarification on a number of specific issues as well as requiring additional disclosures. The core principle of ASC 606 requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. ASC 606 defines a five-step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing U.S. GAAP including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The guidance also requires enhanced disclosures regarding the nature, amount, timing and uncertainty of revenue and cash flows arising from an entity’s contracts with customers. The guidance may be adopted through either retrospective application to all periods presented in the financial statements (full retrospective approach) or through a cumulative effect adjustment to retained earnings at the effective date (modified retrospective approach). The Company had evaluated the effected that will result from adopting the guidance in this standard and concluded that the new revenue standards are not expected to have a material impact on the amount and timing of revenue recognized in the Company’s consolidated financial statements.   In November 2016, the FASB issued ASU 2016-18, “Statement of Cash Flows (Topic 230): Restricted Cash”. These amendments require that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. As a result, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The amendments do not provide a definition of restricted cash or restricted cash equivalents. The amendments in this ASU are effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted. The amendments should be applied using a retrospective transition method to each period presented. The Company has evaluated the impact of adopting ASU 2016-18 noting it will only impact the Company to the extent it has restricted cash in the future.   In July 2017, the FASB issued ASU 2017-11, Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception. For public business entities, the amendments in Part I of this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. For all other entities, the amendments in Part I of this Update are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted for all entities, including adoption in an interim period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. The amendments in Part II of this Update do not require any transition guidance because those amendments do not have an accounting effect. The Company is currently in the process of evaluating the impact of the adoption on its consolidated financial statements.   In February 2018, the FASB issued ASU No. 2018-02 Income Statement—Reporting Comprehensive Income (Topic 220)—Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. The amendments in this Update allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act of 2017. The amendments in this Update affect any entity that is required to apply the provisions of Topic 220, Income Statement-Reporting Comprehensive Income, and has items of other comprehensive income for which the related tax effects are presented in other comprehensive income as required by GAAP. The Company is currently in the process of evaluating the impact of the adoption on its consolidated financial statements.   The Company has considered all new accounting pronouncements and has concluded that there are no new pronouncements that may have a material impact on results of operations, financial condition, or cash flows, based on current information.

NOTe 4 - other receivable   Total other receivable consists of balances of VAT receivable of $17,353 and $33,251 as of June 30, 2018 and December 31, 2017, respectively and other temporary funding receivable from a third party of $69,636 and $0 as of June 30, 2018 and December 31, 2017, respectively. The temporary funding was transferred to the Company’s consulting firm, which makes payments of operating expenses on behalf of the Company.

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">June 30, 2018</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">December 31, 2017</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 45%">Buildings</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,825,466</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,858,989</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Vehicles</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,712</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,912</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Manufacturing equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,132,377</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,133,045</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Office equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">92,474</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">93,961</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Construction in process</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">77,956</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Property, plant, and equipment - total</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,139,985</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,097,907</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Less: accumulated depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(660,738</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(559,327</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Fixed assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,479,247</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,538,580</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

NOTE 9 - INCOME TAX   At June 30, 2018 and December 31, 2017, based on the weight of available evidence, management determined that it was unlikely that the Company's deferred tax assets would be realized and have provided for a full valuation allowance associated with the net deferred tax assets.   The Company periodically analyzes its tax positions taken and expected to be taken and has determined that since inception there has been no need to record a liability for uncertain tax positions. The Company classifies income tax penalties and interest, if any, as part of selling, general and administrative expenses in the accompanying statements of operations. There was no accrued interest or penalties as of June 30, 2018 and December 31, 2017.   The Company is neither under examination by any taxing authority, nor has it been notified of any impending examination.   Under the Law of People’s Republic of China on Enterprise Income Tax (“EIT Law”), which was effective from January 1, 2008, domestically-owned enterprises and foreign-invested enterprises are subject to a uniform tax rate of 25%. The potential benefit of the Company’s net operating losses has not been recognized in these financial statements because it is more likely-than-not the Company will not utilize the net operating losses carried forward as it does not expect to generate sufficient taxable income in future or the amount involved is not significant.    <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">June 30, 2018</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">December 31, 2017</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Current</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt">USA</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: 10pt">China</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Deferred</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt">USA</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 70%; text-align: left; text-indent: 30pt">Deferred tax assets for NOL carryforwards</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">23,626</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">37,893</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: 30pt">Valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(23,626</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(37,893</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt; text-indent: 20pt">Net changes in deferred income tax under non-current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: 10pt">China</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 30pt">NOL carryforwards</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(20,484</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,256</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt; text-indent: 30pt">Valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">20,484</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(18,256</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: 20pt">Net changes in deferred income tax under non-current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total provision for income tax</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>   The tax effects of temporary differences that gave rise to significant portions of deferred tax assets at June 30, 2018 and December 31, 2017 are as follows:    <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">June 30, 2018</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">December 31, 2017</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Deferred Tax Assets:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 45%">Net operating loss carry forwards</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">330,451</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">327,310</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Valuation allowance</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(330,451</td> <td>)</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(327,310</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Net deferred tax assets</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">–</td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">–</td> <td> </td></tr> </table>   A reconciliation between the income tax computed at the U.S. statutory rate and the Company’s provision for income tax in the PRC is as follows:    <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">June 30, 2018</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">December 31, 2017</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 45%; text-align: left">Tax expense at statutory rate-US</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">21%</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">34%</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Foreign income not recognized in the US</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(21%</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(34%</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">PRC enterprise income tax rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Loss not subject to income tax</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(25%</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(25%</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Effective income tax rates</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>   On December 22, 2017, the Tax Cuts and Jobs Act (the Tax Act) was enacted, significantly altering U.S. corporate income tax law. The SEC issued Staff Accounting Bulletin 118, which allows companies to record reasonable estimates of enactment impacts where all of the underlying analysis and calculations are not yet complete. The provisional estimates must be finalized within a one-year measurement period. The Company reduced its net domestic deferred tax asset balance by $88,781 due to the reduction in corporate tax rate from 34% to 21%. These adjustments are fully offset by a change in the Company’s U.S. valuation allowance.

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">June 30, 2018</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">December 31, 2017</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Current</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt">USA</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: 10pt">China</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Deferred</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 10pt">USA</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 70%; text-align: left; text-indent: 30pt">Deferred tax assets for NOL carryforwards</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">23,626</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">37,893</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: 30pt">Valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(23,626</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(37,893</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt; text-indent: 20pt">Net changes in deferred income tax under non-current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: 10pt">China</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 30pt">NOL carryforwards</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(20,484</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,256</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt; text-indent: 30pt">Valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">20,484</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(18,256</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: 20pt">Net changes in deferred income tax under non-current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total provision for income tax</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

note 12 - related party transactions   The related parties of the Company with whom transactions are reported in these financial statements are as follows:   <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 41%; border-bottom: black 1pt solid">Name of Entity or Individual</td> <td style="white-space: nowrap; width: 3%"> </td> <td style="white-space: nowrap; width: 56%; border-bottom: black 1pt solid"> Relationship with the Company and subsidiaries </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="white-space: nowrap">Shandong Yibao Biologics Co, Ltd</td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap">Affiliated company with common shareholders</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td colspan="2" style="white-space: nowrap">Shandong Yibao Import & Export Trading Co, Ltd </td> <td style="white-space: nowrap">Affiliated company with common shareholders</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="white-space: nowrap">Ms. Xiuhua Song</td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap">Director and controlling beneficiary shareholder of the Company </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap">Mr. Hengchun Zhang</td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap">Owner of Shandong Confucian Biologics </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="white-space: nowrap">Mr. Qingbao Kong</td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap">Ms. Xiuhua Song’s spouse</td></tr> </table>   Transactions:   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="6" style="text-align: center">For the Six Months Ended June 30,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2018</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2017</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Sales to Shandong Yibao Biologics Co. Ltd</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">589,651</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">105,476</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Sales to Shandong Yibao Import & Export Trading Co. Ltd</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">45,399</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">589,651</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">150,875</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="6" style="text-align: center">For the Six Months Ended June 30,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2018</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2017</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify; padding-bottom: 1pt">Purchase from Shandong Yibao Biologics Co. Ltd</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</td><td style="width: 13%; border-bottom: Black 1pt solid; text-align: right">–</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</td><td style="width: 13%; border-bottom: Black 1pt solid; text-align: right">113,771</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">113,771</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>    Accounts receivable from related party   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">June 30, 2018</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">December 31, 2017</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify; padding-bottom: 1pt">Accounts receivable from Shandong Yibao Biologics Co. Ltd</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</td><td style="width: 13%; border-bottom: Black 1pt solid; text-align: right">182,365</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</td><td style="width: 13%; border-bottom: Black 1pt solid; text-align: right">–</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">182,365</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>   Due to related parties    <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">June 30, 2018</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">December 31, 2017</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; width: 66%">To Xiuhua Song</td><td style="width: 2%"> </td> <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 13%">2,602,842</td><td style="text-align: left; width: 1%"> </td><td style="width: 2%"> </td> <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 13%">2,630,912</td><td style="text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">To Hengchun Zhang</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">265,479</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">270,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,868,321</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,900,912</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

Transactions:         <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="6" style="text-align: center">For the Six Months Ended June 30,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2018</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2017</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Sales to Shandong Yibao Biologics Co. Ltd</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">589,651</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">105,476</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Sales to Shandong Yibao Import & Export Trading Co. Ltd</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">45,399</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">589,651</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">150,875</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="6" style="text-align: center">For the Six Months Ended June 30,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2018</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2017</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify; padding-bottom: 1pt">Purchase from Shandong Yibao Biologics Co. Ltd</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</td><td style="width: 13%; border-bottom: Black 1pt solid; text-align: right">–</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</td><td style="width: 13%; border-bottom: Black 1pt solid; text-align: right">113,771</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">113,771</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>    Accounts receivable from related party   <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">June 30, 2018</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">December 31, 2017</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify; padding-bottom: 1pt">Accounts receivable from Shandong Yibao Biologics Co. Ltd</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</td><td style="width: 13%; border-bottom: Black 1pt solid; text-align: right">182,365</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</td><td style="width: 13%; border-bottom: Black 1pt solid; text-align: right">–</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">182,365</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>   Due to related parties    <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">June 30, 2018</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">December 31, 2017</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; width: 66%">To Xiuhua Song</td><td style="width: 2%"> </td> <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 13%">2,602,842</td><td style="text-align: left; width: 1%"> </td><td style="width: 2%"> </td> <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 13%">2,630,912</td><td style="text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">To Hengchun Zhang</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">265,479</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">270,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,868,321</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,900,912</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

Principles of Consolidation - The unaudited condensed consolidated financial statements include the accounts of YBCC and its subsidiaries. The Company’s subsidiaries include 51% of Yibaoccyb, YibaoHK and Confucian, of which 49% of Yibaoccyb’s consolidated operating results was shown in non-controlling interest on the consolidated balance sheets.

Use of Estimates - The preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimate and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. The most significant estimates reflected in the condensed consolidated financial statements include allowance for doubtful accounts, allowance for inventory, depreciation, useful lives of property and equipment, deferred income taxes, useful life of intangible assets, and contingencies. Estimates and assumptions are periodically reviewed and the effects of revisions are reflected in the unaudited condensed consolidated financial statements in the period they are determined to be necessary.

NOTE 13 - MAJOR SUPPLIERS AND CUSTOMERS   The Company purchases majority of its inventory and packaging supplies from one supplier which accounted for 22.96% of the total purchases for the six months ended June 30, 2018.   The Company had three major customers for the six months ended June 30, 2018: Shandong Yibao Biologics, a related party, accounted for 54.12% of revenue, Anhui Xiancheng Import and Export Company accounted for 26.30% of revenue, Ping Xiang Import and Export Company accounted for 12.35% of revenue for the six months ended June 30, 2018.   The Company purchases majority of its inventory and packaging supplies from three suppliers which accounted for 31.16%, 23.83% and 15.43% of the total purchases for the six months ended June 30, 2017.   The Company had four major customers for the six months ended June 30, 2017: Ping Xiang Import and Export Company accounted for 22.65% of revenue, Jiangshan Huacheng Import and Export Company accounted for 20.01%, Nanjing Hejian Biologics accounted for 15.98%, and Shandong Yibao Biologics for 11.90% of revenue for the six months ended June 30, 2017.

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 85%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center">June 30,</td><td> </td><td> </td> <td colspan="2" style="text-align: center">December 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2018</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2017</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 55%; text-align: left">Beginning balance</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">292,072</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">304,291</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net income (loss) attributed to non-controlling interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">40,149</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(31,538</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt; text-indent: -10pt">Foreign currency translation gain (loss) attributable to non-controlling interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(6,444</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">19,319</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Ending balance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">325,777</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">292,072</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

NOte 2 - going concern   Net income and net losses for the three months ended June 30, 2018 and 2017 were $79,624 and $123,669, respectively. The Company sustained net losses of $30,570 and $308,239 during the six months ended June 30, 2018 and 2017, respectively. The Company has accumulated deficit of $1,250,396 and $1,179,676 as of June 30, 2018 and December 31, 2017, respectively. The Company’s continuation as a going concern is dependent on its ability to generate sufficient cash flows from operations to meet its obligations and/or obtain additional financing, as may be required.   The accompanying unaudited condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern; however, the above condition raises substantial doubt about the Company’s ability to do so. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern.

EX-101.SCH 8 ybao-20180630.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - 1. Organizations and Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - 2. Going Concern link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - 3. Concentration of Credit Risk link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - 4. Other Receivable link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - 5. Prepaid Expenses link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - 6. Property, Plant and Equipment link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - 7. Intangible Assets - Net link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - 8. Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - 9. Income Tax link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - 10. Equity link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - 11. Non-Controlling Interest link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - 12. Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - 13. Major Suppliers and Customers link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - 14. Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - 1. Organizations and Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - 1. Organizations and Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - 5. Prepaid Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - 6. Property, Plant and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - 7. Intangible Assets - Net (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - 8. Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - 9. Income Tax (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - 11. Non-Controlling Interest (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - 12. Related Party Transactions (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - 1. Organizations and Summary of Significant Accounting Policies (Details - Inventories) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - 1. Organizations and Summary of Significant Accounting Policies (Details - Property life) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - 1. Organizations and Summary of Significant Accounting Policies (Details - Foreign currency translation) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - 1. Organizations and Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - 2. Going Concern (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - 3. Concentration of Credit Risk (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - 4. Other Receivable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - 5. Prepaid Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - 6. Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - 6. Property and Equipment (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - 7. Intangible Assets - Net (Details - land use) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - 7. Intangible Assets - Net (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - 8. Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - 9. Income Tax (Details - Income Tax Provision) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - 9. Income Tax (Details - Deferred tax assets) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - 9. Income Tax (Details - Reconcilation of tax rate) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - 9. Income Tax (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - 10. Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - 11. Non-Controlling Interest (Details) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - 12. Related Party Transactions (Details - Income Stmt) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - 12. Related Party Transactions (Details - Accounts Receivable) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - 12. Related Party Transactions (Details - Due to related parties) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - 13. Major Suppliers and Customers (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 ybao-20180630_cal.xml XBRL CALCULATION FILE EX-101.DEF 10 ybao-20180630_def.xml XBRL DEFINITION FILE EX-101.LAB 11 ybao-20180630_lab.xml XBRL LABEL FILE Property, Plant and Equipment, Type [Axis] Buildings [Member] Office Equipment [Member] Manufacturing equipment [Member] Currency [Axis] China, Yuan Renminbi Intercompany Foreign Currency Balance by Description [Axis] Balance Sheet [Member] Legal Entity [Axis] Yibaoccyb [Member] Yibaoccyb [Member] Yibao HK [Member] Shandong Confucian Biologics [Member] Geographical [Axis] CHINA Balance Sheet Location [Axis] Value Added Tax [Member] Prepaid Professional Fees [Member] Vehicles [Member] Finite-Lived Intangible Assets by Major Class [Axis] May 2013 - April 2063 [Member] Dec. 2015 to Sept 2065 [Member] Dec. 2015 to Sept 2065 [Member] Related Party [Axis] Shandong Yibao Biologics [Member] Xiuhua Song [Member] Hengchun Zhang [Member] UNITED STATES Counterparty Name [Axis] 7 Investors [Member] Concentration Risk Benchmark [Axis] Supplies [Member] Concentration Risk Type [Axis] Supplier 1 [Member] Sales Revenue, Net [Member] Customer [Axis] Anhui Xiancheng Import and Export Company [Member Ping Xiang Import and Export [Member] Shandong Yibao Biologics [Member] Statement of Operations [Member] Class of Stock [Axis] Series B Preferred Stock [Member] Supplier A [Member] Utilities [Member] Other Prepaid Expenses [Member] Income Tax Authority [Axis] USA [Member] China [Member] Valuation Allowance by Deferred Tax Asset [Axis] Temporary Differences [Member] Supplier B [Member] Nanjing Hejian Biologics [Member] Shandong Yibao Import & Export Trading [Member] Supplier C [Member] Jiangshan Huacheng Import and Export [Member] Temporary Funding [Member] Construction in Progress [Member] Document and Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Entity Public Float Statement of Financial Position [Abstract] Assets Current Assets Cash and cash equivalents Accounts receivable - net Accounts receivable - related party Inventory Other receivable Advance to suppliers Prepaid expenses Total current assets Property, plant and equipment - net Intangible assets - net Other assets Deposits Total Assets Liabilities and Equity Current Liabilities Accounts payable Accrued expenses Customer deposits Taxes payable Other payable Other payable - related parties Loan payable Total current liabilities Total liabilities Equity Convertible preferred shares: $0.0001 par value, 50,000,000 shares authorized, 974,370 series A issued and outstanding as of June 30, 2018 and December 31, 2017, respectively Common stock: $0.001 par value, 900,000,000 shares authorized, 9,894,214 shares issued and outstanding of June 30, 2018 and December 31, 2017, respectively Additional paid-in capital Accumulated foreign currency exchange loss Accumulated deficit Total YBCC, Inc. stockholders' equity Non-controlling interest Total equity Total liabilities and equity Convertible preferred shares authorized Convertible preferred shares par value Preferred stock shares issued Preferred stock shares outstanding Common stock shares authorized Common stock par value Common stock shares issued Common stock shares outstanding Income Statement [Abstract] Revenue Cost of goods sold Gross profit Operating Expenses Selling expenses General and administrative expenses Total operating expenses Income (loss) from operations Other income (expenses) Other income (expense) Interest income Total other income Income (loss) before income taxes Provision for income tax Net Income (Loss) Less: net income (loss) attributable to non-controlling interest Net income (loss) attributable to the Company Net Income (Loss) Other Comprehensive Income Foreign currency translation gain/(loss) Comprehensive income (loss) Less: comprehensive income (loss) attributable to non-controlling interest Net comprehensive income (loss) attributable to the Company Net income (loss) per share - basic and diluted Weighted average shares outstanding - basic and diluted Statement of Cash Flows [Abstract] Cash flows used in operating activities: Net loss Adjustments to reconcile net loss to net cash used in operating activities: Depreciation Amortization Changes in operating assets and liabilities: Accounts receivable Accounts receivable-related party Other receivable Advance to suppliers Prepaid expenses Inventory Deposits Accounts payable Accounts payable - related party Accrued expense Customer deposit Customer deposit - related party Tax payable Other payable Cash used in operating activities Cash flow used in investing activities: Deferred cost Purchase of property and equipment Construction in process Cash used in investing activities Cash flow provided by (used in) financing activities: Advance from (repayment to) related party Proceeds from short term borrowing Net cash provided by (used in) financing activities Effects of currency translation on cash and cash equivalents Net decrease in cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Supplementary Disclosures of Cash Flow Income taxes Interest Non-cash investing and financing activities Issuance of common stock for subscription received previously Accounting Policies [Abstract] Organizations and Summary of Significant Accounting Policies Organization, Consolidation and Presentation of Financial Statements [Abstract] Going Concern Concentration of Credit Risk Notes to Financial Statements Other Receivable Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Prepaid Expenses Property, Plant and Equipment [Abstract] EX-101.PRE 12 ybao-20180630_pre.xml XBRL PRESENTATION FILE XML 13 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Jun. 30, 2018	Aug. 14, 2018
Document and Entity Information
Entity Registrant Name	YBCC, Inc.
Entity Central Index Key	0000822997
Document Type	10-Q
Document Period End Date	Jun. 30, 2018
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		9,894,214
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2018

XML 14 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2018	Dec. 31, 2017
Current Assets
Cash and cash equivalents	$ 91,329	$ 369,607
Accounts receivable - net	5,814	0
Accounts receivable - related party	182,365	0
Inventory	373,860	127,335
Other receivable	86,989	33,251
Advance to suppliers	73,223	20,007
Prepaid expenses	39,785	50,753
Total current assets	853,365	600,953
Property, plant and equipment - net	2,479,247	2,538,580
Intangible assets - net	706,157	726,043
Other assets
Deposits	6,005	6,052
Total Assets	4,044,774	3,871,628
Current Liabilities
Accounts payable	187,924	160,625
Accrued expenses	140,098	124,714
Customer deposits	213,628	31,314
Taxes payable	101,286	92,122
Other payable	244,475	313,806
Other payable - related parties	2,868,321	2,900,912
Loan payable	84,629	0
Total current liabilities	3,840,361	3,623,493
Total liabilities	3,840,361	3,623,493
Equity
Convertible preferred shares: $0.0001 par value, 50,000,000 shares authorized, 974,370 series A issued and outstanding as of June 30, 2018 and December 31, 2017, respectively	98	98
Common stock: $0.001 par value, 900,000,000 shares authorized, 9,894,214 shares issued and outstanding of June 30, 2018 and December 31, 2017, respectively	9,894	9,894
Additional paid-in capital	1,162,328	1,162,328
Accumulated foreign currency exchange loss	(43,288)	(36,581)
Accumulated deficit	(1,250,396)	(1,179,676)
Total YBCC, Inc. stockholders' equity	(121,364)	(43,937)
Non-controlling interest	325,777	292,072
Total equity	204,413	248,135
Total liabilities and equity	$ 4,044,774	$ 3,871,628

XML 15 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Jun. 30, 2018	Dec. 31, 2017
Statement of Financial Position [Abstract]
Convertible preferred shares authorized	50,000,000	50,000,000
Convertible preferred shares par value	$ 0.0001	$ 0.0001
Preferred stock shares issued	974,730	974,730
Preferred stock shares outstanding	974,730	974,730
Common stock shares authorized	900,000,000	900,000,000
Common stock par value	$ 0.001	$ 0.001
Common stock shares issued	9,894,214	9,894,214
Common stock shares outstanding	9,894,214	9,894,214

XML 16 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Income Statement [Abstract]
Revenue	$ 674,441	$ 606,693	$ 935,621	$ 886,534
Cost of goods sold	478,897	562,699	698,150	840,716
Gross profit	195,544	43,994	237,471	45,818
Operating Expenses
Selling expenses	7,168	5,120	10,248	13,122
General and administrative expenses	124,843	162,604	268,853	344,001
Total operating expenses	132,011	167,724	279,101	357,123
Income (loss) from operations	63,533	(123,730)	(41,630)	(311,305)
Other income (expenses)
Other income (expense)	15,958	(6)	10,927	2,964
Interest income	133	67	133	102
Total other income	16,091	61	11,060	3,066
Income (loss) before income taxes	79,624	(123,669)	(30,570)	(308,239)
Provision for income tax	0	0	0	0
Net Income (Loss)	79,624	(123,669)	(30,570)	(308,239)
Less: net income (loss) attributable to non-controlling interest	60,488	(13,077)	40,149	(48,905)
Net income (loss) attributable to the Company	19,136	(110,593)	(70,719)	(259,335)
Net Income (Loss)	79,624	(123,669)	(30,570)	(308,239)
Other Comprehensive Income
Foreign currency translation gain/(loss)	(24,249)	8,315	(13,152)	13,716
Comprehensive income (loss)	61,819	(115,354)	(37,278)	(294,523)
Less: comprehensive income (loss) attributable to non-controlling interest	(11,882)	4,074	(6,444)	6,721
Net comprehensive income (loss) attributable to the Company	$ 73,701	$ (119,428)	$ (30,834)	$ (301,244)
Net income (loss) per share - basic and diluted	$ 0.01	$ (0.01)	$ (0.00)	$ (0.03)
Weighted average shares outstanding - basic and diluted	9,894,214	9,891,214	9,894,214	9,861,065

XML 17 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Cash flows used in operating activities:
Net loss	$ (30,570)	$ (308,239)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	115,126	98,708
Amortization	8,035	7,443
Changes in operating assets and liabilities:
Accounts receivable	(6,044)	7,510
Accounts receivable-related party	(189,573)	0
Other receivable	(58,154)	12,044
Advance to suppliers	(55,668)	(37,957)
Prepaid expenses	10,871	6,882
Inventory	(258,486)	(58,107)
Deposits	0	(146)
Accounts payable	31,173	3,194
Accounts payable - related party	0	71,272
Accrued expense	15,639	12,773
Customer deposit	190,065	14,697
Customer deposit - related party	0	(34,736)
Tax payable	11,130	14,431
Other payable	(66,609)	(62,270)
Cash used in operating activities	(283,065)	(252,501)
Cash flow used in investing activities:
Deferred cost	0	14,946
Purchase of property and equipment	(19,028)	(23,387)
Construction in process	(78,548)	0
Cash used in investing activities	(97,576)	(8,441)
Cash flow provided by (used in) financing activities:
Advance from (repayment to) related party	9,693	(148,426)
Proceeds from short term borrowing	87,974	97,532
Net cash provided by (used in) financing activities	97,667	(50,894)
Effects of currency translation on cash and cash equivalents	4,696	460
Net decrease in cash and cash equivalents	(278,278)	(311,379)
Cash and cash equivalents at beginning of period	369,607	339,147
Cash and cash equivalents at end of period	91,329	27,768
Supplementary Disclosures of Cash Flow
Income taxes	0	0
Interest	0	0
Non-cash investing and financing activities
Issuance of common stock for subscription received previously	$ 0	$ 300,000

XML 18 R6.htm IDEA: XBRL DOCUMENT

1. Organizations and Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2018

Accounting Policies [Abstract]

Organizations and Summary of Significant Accounting Policies

NOTE 1 - ORGANIZATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

YibaoHK is a limited liability company incorporated under the laws of the Hong Kong on June 15, 2016, which was formed by Yibaoccyb.

Confucian was founded on October 31, 2012. Confucian is in the Food Industrial Park inside the economic development Zone of JinXiang County, Jining City in the province of Shandong in China.

Details of the Company’s structure as of June 30, 2018 is as follow:

Intercompany accounts and transactions have been eliminated upon consolidation.

Inventories - Inventory is valued at the lower of cost or market. Cost is determined using first-in, first-out method.

Inventory, comprised principally of finished goods, raw material and packaging material, are valued at the lower of cost or market.

	June 30, 2018		December 31, 2017
Finished goods	$	14,502	$	7,106
Work in progress		96,512		47,292
Raw materials		225,671		46,902
Packaging material		37,175		26,035
Total	$	373,860	$	127,335

Revenue Recognition - The Company recognizes product revenue in accordance with ASC 606 . The core principle of ASC 606 is that an entity should recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve the core principle of ASC 606, an entity should take the following actions: Step 1: Identify the contract with a customer; Step 2: Identify the performance obligations in the contract; Step 3: Determine the transaction price; Step 4: Allocate the transaction price; Step 5: Recognize revenue when or as the entity satisfies a performance obligation. The Company complies with ASC 606 revenue recognition and follows the five-step revenue recognition model along with other guidance impacted by this standard.

The exchange rates used to translate amounts in RMB into USD for the purposes of preparing the financial statements were as follows:

Balance sheet
Balance sheet as of June 30, 2018	RMB 6.62 to US $1.00
Balance sheet as of December 31, 2017	RMB 6.51 to US $1.00

Statement of operation and other comprehensive income
Statement of operation and other comprehensive income for three months ended June 30, 2018	RMB 6.38 to US $1.00
Statement of operation and other comprehensive income for three months ended June 30, 2017	RMB 6.86 to US $1.00
Statement of operation and other comprehensive income for six months ended June 30, 2018	RMB 6.37 to US $1.00
Statement of operation and other comprehensive income for six months ended June 30, 2017	RMB 6.87 to US $1.00

Level 1 Inputs— Unadjusted quoted market prices for identical assets and liabilities in an active market that the Company has the ability to access.

Level 2 Inputs— Inputs other than the quoted prices in active markets that are observable either directly or indirectly.

Level 3 Inputs— Inputs based on valuation techniques that are both unobservable and significant to the overall fair value measurements

Recent Accounting Pronouncements

XML 19 R7.htm IDEA: XBRL DOCUMENT

2. Going Concern

6 Months Ended

Jun. 30, 2018

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Going Concern

NOte 2 - going concern

XML 20 R8.htm IDEA: XBRL DOCUMENT

3. Concentration of Credit Risk

6 Months Ended

Jun. 30, 2018

Accounting Policies [Abstract]

Concentration of Credit Risk

NOte 3 - concentration of credit risk

XML 21 R9.htm IDEA: XBRL DOCUMENT

4. Other Receivable

6 Months Ended

Jun. 30, 2018

Notes to Financial Statements

Other Receivable

NOTe 4 - other receivable

XML 22 R10.htm IDEA: XBRL DOCUMENT

5. Prepaid Expenses

6 Months Ended

Jun. 30, 2018

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Prepaid Expenses

NOTe 5 - prepaid expenses

Prepaid expenses were comprised of the following:

	June 30, 2018		December 31, 2017
Utilities	$	1,511	$	1,537
Professional fees		38,274		44,974
Other		–		4,242
Total	$	39,785	$	50,753

XML 23 R11.htm IDEA: XBRL DOCUMENT

6. Property, Plant and Equipment

6 Months Ended

Jun. 30, 2018

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment

Note 6 - property, plant and equipment

Property, plant and equipment as of June 30, 2018 and December 31, 2017 are summarized as following:

	June 30, 2018			December 31, 2017
Buildings	$	1,825,466		$	1,858,989
Vehicles		11,712			11,912
Manufacturing equipment		1,132,377			1,133,045
Office equipment		92,474			93,961
Construction in process		77,956			–
Property, plant, and equipment - total		3,139,985			3,097,907
Less: accumulated depreciation		(660,738	)		(559,327	)
Fixed assets, net	$	2,479,247		$	2,538,580

XML 24 R12.htm IDEA: XBRL DOCUMENT

7. Intangible Assets - Net

6 Months Ended

Jun. 30, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets - Net

note 7 - intangible assets -net

The summary of land use rights as of June 30, 2018 and December 31, 2017 are summarized as following:

The land use right term	June 30, 2018			December 31, 2017
May, 2013 - Apr. 2063	$	544,066		$	553,332
Dec. 2015 - Sept. 2065		204,017			207,491
Dec. 2015 – Sept. 2065		24,830			25,252
Intangible assets- total		772,913			786,075
Less: accumulated amortization		(66,756	)		(60,032	)
Intangible assets, net	$	706,157		$	726,043

XML 25 R13.htm IDEA: XBRL DOCUMENT

8. Commitments and Contingencies

6 Months Ended

Jun. 30, 2018

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

NOTE 8 - COMMITMENTS AND CONTINGENCIES

	Amount
2018 calendar year	$	6,126
Total	$	6,126

XML 26 R14.htm IDEA: XBRL DOCUMENT

9. Income Tax

6 Months Ended

Jun. 30, 2018

Income Tax Disclosure [Abstract]

Income Tax

NOTE 9 - INCOME TAX

The Company is neither under examination by any taxing authority, nor has it been notified of any impending examination.

	June 30, 2018			December 31, 2017
Current
USA	$	–		$	–
China		–			–

Deferred
USA
Deferred tax assets for NOL carryforwards		23,626			37,893
Valuation allowance		(23,626	)		(37,893	)
Net changes in deferred income tax under non-current portion		–			–

China
NOL carryforwards		(20,484	)		18,256
Valuation allowance		20,484			(18,256	)
Net changes in deferred income tax under non-current portion		–			–

Total provision for income tax	$	–		$	–

The tax effects of temporary differences that gave rise to significant portions of deferred tax assets at June 30, 2018 and December 31, 2017 are as follows:

	June 30, 2018			December 31, 2017
Deferred Tax Assets:
Net operating loss carry forwards	$	330,451		$	327,310
Valuation allowance		(330,451	)		(327,310	)
Net deferred tax assets	$	–		$	–

A reconciliation between the income tax computed at the U.S. statutory rate and the Company’s provision for income tax in the PRC is as follows:

	June 30, 2018			December 31, 2017
Tax expense at statutory rate-US		21%			34%
Foreign income not recognized in the US		(21%	)		(34%	)
PRC enterprise income tax rate		25%			25%
Loss not subject to income tax		(25%	)		(25%	)
Effective income tax rates		–			–

XML 27 R15.htm IDEA: XBRL DOCUMENT

10. Equity

6 Months Ended

Jun. 30, 2018

Equity

Equity

note 10 - equity

Common Stock:

On July 1, 2016, the Company issued 3,915,000 shares of common stock to Ms. Song in connection with the change of control.

On August 31, 2016, the Company cancelled 3,915,000 shares of outstanding shares belonging to Standard.

On December 22, 2016, the Company issued 350,000 shares for legal counsel services valued at $35,000.

As a result of all common stock issuances, the total issued and outstanding shares of common stock were 9,894,214 as of June 30, 2018 and December 31, 2017, respectively.

Series A Preferred Shares:

XML 28 R16.htm IDEA: XBRL DOCUMENT

11. Non-Controlling Interest

6 Months Ended

Jun. 30, 2018

Noncontrolling Interest [Abstract]

Non-Controlling Interest

NOTE 11 - NON-CONTROLLING INTEREST

Non-controlling interest consisted of the following:

	June 30,			December 31,
	2018			2017
Beginning balance	$	292,072		$	304,291
Net income (loss) attributed to non-controlling interest		40,149			(31,538	)
Foreign currency translation gain (loss) attributable to non-controlling interest		(6,444	)		19,319
Ending balance	$	325,777		$	292,072

XML 29 R17.htm IDEA: XBRL DOCUMENT

12. Related Party Transactions

6 Months Ended

Jun. 30, 2018

Related Party Transactions

note 12 - related party transactions

The related parties of the Company with whom transactions are reported in these financial statements are as follows:

Name of Entity or Individual		Relationship with the Company and subsidiaries
Shandong Yibao Biologics Co, Ltd		Affiliated company with common shareholders
Shandong Yibao Import & Export Trading Co, Ltd		Affiliated company with common shareholders
Ms. Xiuhua Song		Director and controlling beneficiary shareholder of the Company
Mr. Hengchun Zhang		Owner of Shandong Confucian Biologics
Mr. Qingbao Kong		Ms. Xiuhua Song’s spouse

Transactions:

	For the Six Months Ended June 30,
	2018		2017
Sales to Shandong Yibao Biologics Co. Ltd	$	589,651	$	105,476
Sales to Shandong Yibao Import & Export Trading Co. Ltd		–	$	45,399
Total	$	589,651	$	150,875

	For the Six Months Ended June 30,
	2018		2017
Purchase from Shandong Yibao Biologics Co. Ltd	$	–	$	113,771
Total	$	–	$	113,771

Accounts receivable from related party

	June 30, 2018		December 31, 2017
Accounts receivable from Shandong Yibao Biologics Co. Ltd	$	182,365	$	–
Total	$	182,365	$	–

Due to related parties

	June 30, 2018		December 31, 2017
To Xiuhua Song	$	2,602,842	$	2,630,912
To Hengchun Zhang		265,479		270,000
Total	$	2,868,321	$	2,900,912

XML 30 R18.htm IDEA: XBRL DOCUMENT

13. Major Suppliers and Customers

6 Months Ended

Jun. 30, 2018

Risks and Uncertainties [Abstract]

Major Suppliers and Customers

NOTE 13 - MAJOR SUPPLIERS AND CUSTOMERS

The Company purchases majority of its inventory and packaging supplies from one supplier which accounted for 22.96% of the total purchases for the six months ended June 30, 2018.

XML 31 R19.htm IDEA: XBRL DOCUMENT

14. Subsequent Events

6 Months Ended

Jun. 30, 2018

Subsequent Events [Abstract]

Subsequent Events

NOTE 14 - SUBSEQUENT EVENTS

XML 32 R20.htm IDEA: XBRL DOCUMENT

1. Organizations and Summary of Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2018

Accounting Policies [Abstract]

Organization and Operations

YibaoHK is a limited liability company incorporated under the laws of the Hong Kong on June 15, 2016, which was formed by Yibaoccyb.

Confucian was founded on October 31, 2012. Confucian is in the Food Industrial Park inside the economic development Zone of JinXiang County, Jining City in the province of Shandong in China.

Details of the Company’s structure as of June 30, 2018 is as follow:

Reverse Merger Accounting

Reverse Merger Accounting – Since YBCC and Yibaoccyb were entities under Mrs. Song’s common control prior to the share exchange, the transaction was accounted for as a restructuring transaction in accordance with generally accepted accounting principles in the United States ("GAAP"). YBCC has recast prior period unaudited consolidated financial statements to reflect the conveyance of Yibaoccyb’s common shares as if the restructuring transaction had occurred as of the earliest date of the unaudited consolidated financial statements.

Basis of Presentation

Principles of Consolidation

Use of Estimates

Inventories

Inventories - Inventory is valued at the lower of cost or market. Cost is determined using first-in, first-out method.

Inventory, comprised principally of finished goods, raw material and packaging material, are valued at the lower of cost or market.

	June 30, 2018		December 31, 2017
Finished goods	$	14,502	$	7,106
Work in progress		96,512		47,292
Raw materials		225,671		46,902
Packaging material		37,175		26,035
Total	$	373,860	$	127,335

Revenue Recognition

Revenue Recognition - The Company recognizes product revenue in accordance with ASC 606 . The core principle of ASC 606 is that an entity should recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve the core principle of ASC 606, an entity should take the following actions: Step 1: Identify the contract with a customer; Step 2: Identify the performance obligations in the contract; Step 3: Determine the transaction price; Step 4 Allocate the transaction price; Step 5: Recognize revenue when or as the entity satisfies a performance obligation. The Company complies with ASC 606 revenue recognition and follows the five-step revenue recognition model along with other guidance impacted by this standard.

Impairment of Long-Lived Assets

Foreign Currency Translation

The exchange rates used to translate amounts in RMB into USD for the purposes of preparing the financial statements were as follows:

Balance sheet
Balance sheet as of June 30, 2018	RMB 6.62 to US $1.00
Balance sheet as of December 31, 2017	RMB 6.51 to US $1.00

Statement of operation and other comprehensive income
Statement of operation and other comprehensive income for three months ended June 30, 2018	RMB 6.38 to US $1.00
Statement of operation and other comprehensive income for three months ended June 30, 2017	RMB 6.86 to US $1.00
Statement of operation and other comprehensive income for six months ended June 30, 2018	RMB 6.37 to US $1.00
Statement of operation and other comprehensive income for six months ended June 30, 2017	RMB 6.87 to US $1.00

Fair Value of Financial Instruments

Level 1 Inputs— Unadjusted quoted market prices for identical assets and liabilities in an active market that the Company has the ability to access.

Level 2 Inputs— Inputs other than the quoted prices in active markets that are observable either directly or indirectly.

Level 3 Inputs— Inputs based on valuation techniques that are both unobservable and significant to the overall fair value measurements

Net Earnings (Loss) Per Share

Reclassifications

Recent Accounting Pronouncements

Recent Accounting Pronouncements

XML 33 R21.htm IDEA: XBRL DOCUMENT

1. Organizations and Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2018

Accounting Policies [Abstract]

Schedule of inventory

	June 30, 2018		December 31, 2017
Finished goods	$	14,502	$	7,106
Work in progress		96,512		47,292
Raw materials		225,671		46,902
Packaging material		37.175		26,035
Total	$	373,860	$	127,335

Property, plant and equipment useful lives

Category	Estimated Life	Method
Manufacturing equipment	10	Straight Line
Office equipment	5	Straight Line
Buildings	20	Straight Line

Foreign currency exchange rates

Balance sheet
Balance sheet as of June 30, 2018	RMB 6.62 to US $1.00
Balance sheet as of December 31, 2017	RMB 6.51 to US $1.00

Statement of operation and other comprehensive income
Statement of operation and other comprehensive income for three months ended June 30, 2018	RMB 6.38 to US $1.00
Statement of operation and other comprehensive income for three months ended June 30, 2017	RMB 6.86 to US $1.00
Statement of operation and other comprehensive income for six months ended June 30, 2018	RMB 6.37 to US $1.00
Statement of operation and other comprehensive income for six months ended June 30, 2017	RMB 6.87 to US $1.00

XML 34 R22.htm IDEA: XBRL DOCUMENT

5. Prepaid Expenses (Tables)

6 Months Ended

Jun. 30, 2018

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Schedule of Prepaid Expenses

	June 30, 2018		December 31, 2017
Utilities	$	1,511	$	1,537
Professional fees		38,274		44,974
Other		–		4,242
Total	$	39,785	$	50,753

XML 35 R23.htm IDEA: XBRL DOCUMENT

6. Property, Plant and Equipment (Tables)

6 Months Ended

Jun. 30, 2018

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment

	June 30, 2018			December 31, 2017
Buildings	$	1,825,466		$	1,858,989
Vehicles		11,712			11,912
Manufacturing equipment		1,132,377			1,133,045
Office equipment		92,474			93,961
Construction in process		77,956			–
Property, plant, and equipment - total		3,139,985			3,097,907
Less: accumulated depreciation		(660,738	)		(559,327	)
Fixed assets, net	$	2,479,247		$	2,538,580

XML 36 R24.htm IDEA: XBRL DOCUMENT

7. Intangible Assets - Net (Tables)

6 Months Ended

Jun. 30, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

Summary of land use rights

The land use right term	June 30, 2018			December 31, 2017
May, 2013 - Apr. 2063	$	544,066		$	553,332
Dec. 2015 - Sept. 2065		204,017			207,491
Dec. 2015 – Sept. 2065		24,830			25,252
Intangible assets- total		772,913			786,075
Less: accumulated amortization		(66,756	)		(60,032	)
Intangible assets, net	$	706,157		$	726,043

XML 37 R25.htm IDEA: XBRL DOCUMENT

8. Commitments and Contingencies (Tables)

6 Months Ended

Jun. 30, 2018

Commitments and Contingencies Disclosure [Abstract]

Schedule of future operating lease payments

	Amount
2018 calendar year	$	6,126
Total	$	6,126

XML 38 R26.htm IDEA: XBRL DOCUMENT

9. Income Tax (Tables)

6 Months Ended

Jun. 30, 2018

Income Tax Disclosure [Abstract]

Calculation of provision for income taxes

	June 30, 2018			December 31, 2017
Current
USA	$	–		$	–
China		–			–

Deferred
USA
Deferred tax assets for NOL carryforwards		23,626			37,893
Valuation allowance		(23,626	)		(37,893	)
Net changes in deferred income tax under non-current portion		–			–

China
NOL carryforwards		(20,484	)		18,256
Valuation allowance		20,484			(18,256	)
Net changes in deferred income tax under non-current portion		–			–

Total provision for income tax	$	–		$	–

Deferred tax assets

	June 30, 2018			December 31, 2017
Deferred Tax Assets:
Net operating loss carry forwards	$	330,451		$	327,310
Valuation allowance		(330,451	)		(327,310	)
Net deferred tax assets	$	–		$	–

Reconciliation of effective income tax rate

	June 30, 2018			December 31, 2017
Tax expense at statutory rate-US		21%			34%
Foreign income not recognized in the US		(21%	)		(34%	)
PRC enterprise income tax rate		25%			25%
Loss not subject to income tax		(25%	)		(25%	)
Effective income tax rates		–			–

XML 39 R27.htm IDEA: XBRL DOCUMENT

11. Non-Controlling Interest (Tables)

6 Months Ended

Jun. 30, 2018

Noncontrolling Interest [Abstract]

Schedule of non-controlling interests

	June 30,			December 31,
	2018			2017
Beginning balance	$	292,072		$	304,291
Net income (loss) attributed to non-controlling interest		40,149			(31,538	)
Foreign currency translation gain (loss) attributable to non-controlling interest		(6,444	)		19,319
Ending balance	$	325,777		$	292,072

XML 40 R28.htm IDEA: XBRL DOCUMENT

12. Related Party Transactions (Tables)

6 Months Ended

Jun. 30, 2018

Schedule of related entities

Name of Entity or Individual		Relationship with the Company and subsidiaries
Shandong Yibao Biologics Co, Ltd		Affiliated company with common shareholders
Shandong Yibao Import & Export Trading Co, Ltd		Affiliated company with common shareholders
Ms. Xiuhua Song		Director and controlling beneficiary shareholder of the Company
Mr. Hengchun Zhang		Owner of Shandong Confucian Biologics
Mr. Qingbao Kong		Ms. Xiuhua Song’s spouse

Related party payables

Transactions:

	For the Six Months Ended June 30,
	2018		2017
Sales to Shandong Yibao Biologics Co. Ltd	$	589,651	$	105,476
Sales to Shandong Yibao Import & Export Trading Co. Ltd		–	$	45,399
Total	$	589,651	$	150,875

	For the Six Months Ended June 30,
	2018		2017
Purchase from Shandong Yibao Biologics Co. Ltd	$	–	$	113,771
Total	$	–	$	113,771

Accounts receivable from related party

	June 30, 2018		December 31, 2017
Accounts receivable from Shandong Yibao Biologics Co. Ltd	$	182,365	$	–
Total	$	182,365	$	–

Due to related parties

	June 30, 2018		December 31, 2017
To Xiuhua Song	$	2,602,842	$	2,630,912
To Hengchun Zhang		265,479		270,000
Total	$	2,868,321	$	2,900,912

XML 41 R29.htm IDEA: XBRL DOCUMENT

1. Organizations and Summary of Significant Accounting Policies (Details - Inventories) - USD ($)	Jun. 30, 2018	Dec. 31, 2017
Accounting Policies [Abstract]
Finished goods	$ 14,502	$ 7,106
Work in progress	96,512	47,292
Raw materials	225,671	46,902
Packaging material	37,175	26,035
Total	$ 373,860	$ 127,335

XML 42 R30.htm IDEA: XBRL DOCUMENT

1. Organizations and Summary of Significant Accounting Policies (Details - Property life)	6 Months Ended
	Jun. 30, 2018
Manufacturing equipment [Member]
Estimated life	10 years
Office Equipment [Member]
Estimated life	5 years
Buildings [Member]
Estimated life	20 years

XML 43 R31.htm IDEA: XBRL DOCUMENT

1. Organizations and Summary of Significant Accounting Policies (Details - Foreign currency translation) - China, Yuan Renminbi	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Dec. 31, 2017
Balance Sheet [Member]
Foreign Currency Exchange Rate Translation	6.62		6.62		6.51
Statement of Operations [Member]
Foreign Currency Exchange Rate Translation	6.38	6.86	6.37	6.87

XML 44 R32.htm IDEA: XBRL DOCUMENT

1. Organizations and Summary of Significant Accounting Policies (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Dec. 31, 2017
Accounts receivable	$ 188,179		$ 0
Asset impairment	0	$ 0
Uncertain tax positions	$ 0		$ 0
Enterprise income tax	25.00%
Antidilutive securities	0	0
Yibaoccyb [Member]
Ownership percentage	51.00%
Noncontrolling interest	49.00%
Yibaoccyb [Member]
Place of incorporation	BVI Company
Yibao HK [Member]
Ownership percentage	100.00%
Place of incorporation	Hong Kong Company
Shandong Confucian Biologics [Member]
Ownership percentage	100.00%
Place of incorporation	China Operating Company

XML 45 R33.htm IDEA: XBRL DOCUMENT

2. Going Concern (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
2. Going Concern (Details Narrative) - USD ($)	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Dec. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net losses	$ 79,624	$ (123,669)	$ (30,570)	$ (308,239)
Accumulated deficit	$ (1,250,396)		$ (1,250,396)		$ (1,179,676)

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4591551-111686

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3000-108585

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=84234705&loc=SL4591552-111686

+ Details

XML 46 R34.htm IDEA: XBRL DOCUMENT

3. Concentration of Credit Risk (Details Narrative) - USD ($)	Jun. 30, 2018	Dec. 31, 2017	Jun. 30, 2017	Dec. 31, 2016
Cash	$ 91,329	$ 369,607	$ 27,768	$ 339,147
Cash in excess of FDIC limits	0	0
CHINA
Cash	53,213	307,361
UNITED STATES
Cash	$ 38,116	$ 62,246

XML 47 R35.htm IDEA: XBRL DOCUMENT

4. Other Receivable (Details Narrative) - USD ($)	Jun. 30, 2018	Dec. 31, 2017
Other receivable	$ 86,989	$ 33,251
Value Added Tax [Member]
Other receivable	17,353	33,251
Temporary Funding [Member]
Other receivable	$ 69,636	$ 0

XML 48 R36.htm IDEA: XBRL DOCUMENT

5. Prepaid Expenses (Details) - USD ($)	Jun. 30, 2018	Dec. 31, 2017
Prepaid expenses	$ 39,785	$ 50,753
Utilities [Member]
Prepaid expenses	1,511	1,537
Prepaid Professional Fees [Member]
Prepaid expenses	38,274	44,974
Other Prepaid Expenses [Member]
Prepaid expenses	$ 0	$ 4,242

XML 49 R37.htm IDEA: XBRL DOCUMENT

6. Property and Equipment (Details) - USD ($)	Jun. 30, 2018	Dec. 31, 2017
Property and equipment gross	$ 3,139,985	$ 3,097,907
Less accumulated depreciation	(660,738)	(559,327)
Property and equipment net	2,479,247	2,538,580
Buildings [Member]
Property and equipment gross	1,825,466	1,858,989
Vehicles [Member]
Property and equipment gross	11,712	11,912
Manufacturing equipment [Member]
Property and equipment gross	1,132,377	1,133,045
Office Equipment [Member]
Property and equipment gross	92,474	93,961
Construction in Progress [Member]
Property and equipment gross	$ 77,956	$ 0

XML 50 R38.htm IDEA: XBRL DOCUMENT

6. Property and Equipment (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
6. Property and Equipment (Details Narrative) - USD ($)	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 57,623	$ 49,794	$ 115,126	$ 98,708

XML 51 R39.htm IDEA: XBRL DOCUMENT

7. Intangible Assets - Net (Details - land use) - USD ($)	Jun. 30, 2018	Dec. 31, 2017
Intangible assets, gross	$ 772,913	$ 786,075
Less: accumulated amortization	(66,756)	(60,032)
Intangible assets, net	706,157	726,043
May 2013 - April 2063 [Member]
Intangible assets, gross	544,066	553,332
Dec. 2015 to Sept 2065 [Member]
Intangible assets, gross	204,017	207,491
Dec. 2015 to Sept 2065 [Member]
Intangible assets, gross	$ 24,830	$ 25,252

XML 52 R40.htm IDEA: XBRL DOCUMENT

7. Intangible Assets - Net (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization	$ 4,010	$ 3,729	$ 8,035	$ 7,443
Land use term			50 years

XML 53 R41.htm IDEA: XBRL DOCUMENT

8. Commitments and Contingencies (Details)	Jun. 30, 2018 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Future lease commitment, 2018 calendar year	$ 6,126
Future lease commitment	$ 6,126

XML 54 R42.htm IDEA: XBRL DOCUMENT

9. Income Tax (Details - Income Tax Provision) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Current
USA			$ 0	$ 0
China			0	0
Total provision for income tax	$ 0	$ 0	0	0
USA [Member]
Current
Deferred tax assets for NOL carryforwards	23,626	37,893	23,626	37,893
Valuation allowance	(23,626)	(37,893)	(23,626)	(37,893)
Net changes in deferred income tax under non-current portion	0	0	0	0
China [Member]
Current
Deferred tax assets for NOL carryforwards	(20,484)	18,256	(20,484)	18,256
Valuation allowance	20,484	(18,256)	20,484	(18,256)
Net changes in deferred income tax under non-current portion	$ 0	$ 0	$ 0	$ 0

XML 55 R43.htm IDEA: XBRL DOCUMENT

9. Income Tax (Details - Deferred tax assets) - Temporary Differences [Member] - USD ($)	Jun. 30, 2018	Dec. 31, 2017
Net operating loss carry forwards	$ 330,451	$ 327,310
Valuation allowance	(330,451)	(327,310)
Net deferred tax assets	$ 0	$ 0

XML 56 R44.htm IDEA: XBRL DOCUMENT

9. Income Tax (Details - Reconcilation of tax rate)	6 Months Ended	12 Months Ended
9. Income Tax (Details - Reconcilation of tax rate)	Jun. 30, 2018	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Tax expense at statutory rate-US	21.00%	34.00%
Foreign income not recognized in the US	(21.00%)	(34.00%)
PRC enterprise income tax rate	25.00%	25.00%
Loss not subject to income tax	(25.00%)	(25.00%)
Effective income tax rates	0.00%	0.00%

XML 57 R45.htm IDEA: XBRL DOCUMENT

9. Income Tax (Details Narrative)	6 Months Ended
9. Income Tax (Details Narrative)	Jun. 30, 2018 USD ($)
Income Tax Disclosure [Abstract]
Decrease in deferred tax asset	$ (88,781)

XML 58 R46.htm IDEA: XBRL DOCUMENT

10. Equity (Details Narrative) - shares	12 Months Ended
10. Equity (Details Narrative) - shares	Dec. 31, 2017	Jun. 30, 2018
Preferred stock shares issued	974,730	974,730
Preferred stock shares outstanding	974,730	974,730
Series B Preferred Stock [Member]
Preferred stock shares issued	0	0
Preferred stock shares outstanding	0	0
7 Investors [Member]
Stock issued new, shares	3,000,000

XML 59 R47.htm IDEA: XBRL DOCUMENT

11. Non-Controlling Interest (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
11. Non-Controlling Interest (Details) - USD ($)	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Dec. 31, 2017
Noncontrolling Interest [Abstract]
Beginning balance			$ 292,072	$ 304,291	$ 304,291
Net income (loss) attributed to non-controlling interest	$ 60,488	$ (13,077)	40,149	$ (48,905)	(31,538)
Foreign currency translation gain (loss) attributable to non-controlling interest			(6,444)		19,319
Ending balance	$ 325,777		$ 325,777		$ 292,072

XML 60 R48.htm IDEA: XBRL DOCUMENT

12. Related Party Transactions (Details - Income Stmt) - USD ($)	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Sales to related parties	$ 589,651	$ 150,875
Purchases from related parties	0	113,771
Shandong Yibao Biologics [Member]
Sales to related parties	589,651	105,476
Purchases from related parties	0	113,771
Shandong Yibao Import & Export Trading [Member]
Sales to related parties	$ 0	$ 45,399

XML 61 R49.htm IDEA: XBRL DOCUMENT

12. Related Party Transactions (Details - Accounts Receivable) - USD ($)	Jun. 30, 2018	Dec. 31, 2017
Accounts receivable from related party	$ 182,365	$ 0
Shandong Yibao Biologics [Member]
Accounts receivable from related party	$ 182,365	$ 0

XML 62 R50.htm IDEA: XBRL DOCUMENT

12. Related Party Transactions (Details - Due to related parties) - USD ($)	Jun. 30, 2018	Dec. 31, 2017
Due to related parties	$ 2,868,321	$ 2,900,912
Xiuhua Song [Member]
Due to related parties	2,602,842	2,630,912
Hengchun Zhang [Member]
Due to related parties	$ 265,479	$ 270,000

XML 63 R51.htm IDEA: XBRL DOCUMENT

13. Major Suppliers and Customers (Details Narrative)	6 Months Ended
13. Major Suppliers and Customers (Details Narrative)	Jun. 30, 2018	Jun. 30, 2017
Supplies [Member] \| Supplier 1 [Member]
Concentration risk	22.96%
Supplies [Member] \| Supplier A [Member]
Concentration risk		31.16%
Supplies [Member] \| Supplier B [Member]
Concentration risk		23.83%
Supplies [Member] \| Supplier C [Member]
Concentration risk		15.43%
Sales Revenue, Net [Member] \| Shandong Yibao Biologics [Member]
Concentration risk	54.12%	11.90%
Sales Revenue, Net [Member] \| Anhui Xiancheng Import and Export Company [Member
Concentration risk	26.30%
Sales Revenue, Net [Member] \| Ping Xiang Import and Export [Member]
Concentration risk	12.35%	22.65%
Sales Revenue, Net [Member] \| Jiangshan Huacheng Import and Export [Member]
Concentration risk		20.01%
Sales Revenue, Net [Member] \| Nanjing Hejian Biologics [Member]
Concentration risk		15.98%

EXCEL 64 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 65 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 66 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 68 FilingSummary.xml IDEA: XBRL DOCUMENT 3.10.0.1 html 85 183 1 false 42 0 false 5 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://ybcc.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://ybcc.com/role/BalanceSheets Condensed Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://ybcc.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) Sheet http://ybcc.com/role/StatementsOfOperationsAndComprehensiveIncome Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://ybcc.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 00000006 - Disclosure - 1. Organizations and Summary of Significant Accounting Policies Sheet http://ybcc.com/role/OrganizationsAndSummaryOfSignificantAccountingPolicies 1. Organizations and Summary of Significant Accounting Policies Notes 6 false false R7.htm 00000007 - Disclosure - 2. Going Concern Sheet http://ybcc.com/role/GoingConcern 2. Going Concern Notes 7 false false R8.htm 00000008 - Disclosure - 3. Concentration of Credit Risk Sheet http://ybcc.com/role/ConcentrationOfCreditRisk 3. Concentration of Credit Risk Notes 8 false false R9.htm 00000009 - Disclosure - 4. Other Receivable Sheet http://ybcc.com/role/OtherReceivable 4. Other Receivable Notes 9 false false R10.htm 00000010 - Disclosure - 5. Prepaid Expenses Sheet http://ybcc.com/role/PrepaidExpenses 5. Prepaid Expenses Notes 10 false false R11.htm 00000011 - Disclosure - 6. Property, Plant and Equipment Sheet http://ybcc.com/role/PropertyPlantAndEquipment 6. Property, Plant and Equipment Notes 11 false false R12.htm 00000012 - Disclosure - 7. Intangible Assets - Net Sheet http://ybcc.com/role/IntangibleAssets-Net 7. Intangible Assets - Net Notes 12 false false R13.htm 00000013 - Disclosure - 8. Commitments and Contingencies Sheet http://ybcc.com/role/CommitmentsAndContingencies 8. Commitments and Contingencies Notes 13 false false R14.htm 00000014 - Disclosure - 9. Income Tax Sheet http://ybcc.com/role/IncomeTax 9. Income Tax Notes 14 false false R15.htm 00000015 - Disclosure - 10. Equity Sheet http://ybcc.com/role/Equity 10. Equity Notes 15 false false R16.htm 00000016 - Disclosure - 11. Non-Controlling Interest Sheet http://ybcc.com/role/Non-controllingInterest 11. Non-Controlling Interest Notes 16 false false R17.htm 00000017 - Disclosure - 12. Related Party Transactions Sheet http://ybcc.com/role/RelatedPartyTransactions 12. Related Party Transactions Notes 17 false false R18.htm 00000018 - Disclosure - 13. Major Suppliers and Customers Sheet http://ybcc.com/role/MajorSuppliersAndCustomers 13. Major Suppliers and Customers Notes 18 false false R19.htm 00000019 - Disclosure - 14. Subsequent Events Sheet http://ybcc.com/role/SubsequentEvents 14. Subsequent Events Notes 19 false false R20.htm 00000020 - Disclosure - 1. Organizations and Summary of Significant Accounting Policies (Policies) Sheet http://ybcc.com/role/OrganizationsAndSummaryOfSignificantAccountingPoliciesPolicies 1. Organizations and Summary of Significant Accounting Policies (Policies) Policies http://ybcc.com/role/OrganizationsAndSummaryOfSignificantAccountingPolicies 20 false false R21.htm 00000021 - Disclosure - 1. Organizations and Summary of Significant Accounting Policies (Tables) Sheet http://ybcc.com/role/OrganizationsAndSummaryOfSignificantAccountingPoliciesTables 1. Organizations and Summary of Significant Accounting Policies (Tables) Tables http://ybcc.com/role/OrganizationsAndSummaryOfSignificantAccountingPolicies 21 false false R22.htm 00000022 - Disclosure - 5. Prepaid Expenses (Tables) Sheet http://ybcc.com/role/PrepaidExpensesTables 5. Prepaid Expenses (Tables) Tables http://ybcc.com/role/PrepaidExpenses 22 false false R23.htm 00000023 - Disclosure - 6. Property, Plant and Equipment (Tables) Sheet http://ybcc.com/role/PropertyPlantAndEquipmentTables 6. Property, Plant and Equipment (Tables) Tables http://ybcc.com/role/PropertyPlantAndEquipment 23 false false R24.htm 00000024 - Disclosure - 7. Intangible Assets - Net (Tables) Sheet http://ybcc.com/role/IntangibleAssets-NetTables 7. Intangible Assets - Net (Tables) Tables http://ybcc.com/role/IntangibleAssets-Net 24 false false R25.htm 00000025 - Disclosure - 8. Commitments and Contingencies (Tables) Sheet http://ybcc.com/role/CommitmentsAndContingenciesTables 8. Commitments and Contingencies (Tables) Tables http://ybcc.com/role/CommitmentsAndContingencies 25 false false R26.htm 00000026 - Disclosure - 9. Income Tax (Tables) Sheet http://ybcc.com/role/IncomeTaxTables 9. Income Tax (Tables) Tables http://ybcc.com/role/IncomeTax 26 false false R27.htm 00000027 - Disclosure - 11. Non-Controlling Interest (Tables) Sheet http://ybcc.com/role/Non-controllingInterestTables 11. Non-Controlling Interest (Tables) Tables http://ybcc.com/role/Non-controllingInterest 27 false false R28.htm 00000028 - Disclosure - 12. Related Party Transactions (Tables) Sheet http://ybcc.com/role/RelatedPartyTransactionsTables 12. Related Party Transactions (Tables) Tables http://ybcc.com/role/RelatedPartyTransactions 28 false false R29.htm 00000029 - Disclosure - 1. Organizations and Summary of Significant Accounting Policies (Details - Inventories) Sheet http://ybcc.com/role/OrganizationsAndSummaryOfSignificantAccountingPoliciesDetails-Inventories 1. Organizations and Summary of Significant Accounting Policies (Details - Inventories) Details http://ybcc.com/role/OrganizationsAndSummaryOfSignificantAccountingPoliciesTables 29 false false R30.htm 00000030 - Disclosure - 1. Organizations and Summary of Significant Accounting Policies (Details - Property life) Sheet http://ybcc.com/role/OrganizationsAndSummaryOfSignificantAccountingPoliciesDetails-PropertyLife 1. Organizations and Summary of Significant Accounting Policies (Details - Property life) Details http://ybcc.com/role/OrganizationsAndSummaryOfSignificantAccountingPoliciesTables 30 false false R31.htm 00000031 - Disclosure - 1. Organizations and Summary of Significant Accounting Policies (Details - Foreign currency translation) Sheet http://ybcc.com/role/OrganizationsAndSummaryOfSignificantAccountingPoliciesDetails-ForeignCurrencyTranslation 1. Organizations and Summary of Significant Accounting Policies (Details - Foreign currency translation) Details http://ybcc.com/role/OrganizationsAndSummaryOfSignificantAccountingPoliciesTables 31 false false R32.htm 00000032 - Disclosure - 1. Organizations and Summary of Significant Accounting Policies (Details Narrative) Sheet http://ybcc.com/role/OrganizationsAndSummaryOfSignificantAccountingPoliciesDetailsNarrative 1. Organizations and Summary of Significant Accounting Policies (Details Narrative) Details http://ybcc.com/role/OrganizationsAndSummaryOfSignificantAccountingPoliciesTables 32 false false R33.htm 00000033 - Disclosure - 2. Going Concern (Details Narrative) Sheet http://ybcc.com/role/GoingConcernDetailsNarrative 2. Going Concern (Details Narrative) Details http://ybcc.com/role/GoingConcern 33 false false R34.htm 00000034 - Disclosure - 3. Concentration of Credit Risk (Details Narrative) Sheet http://ybcc.com/role/ConcentrationOfCreditRiskDetailsNarrative 3. Concentration of Credit Risk (Details Narrative) Details http://ybcc.com/role/ConcentrationOfCreditRisk 34 false false R35.htm 00000035 - Disclosure - 4. Other Receivable (Details Narrative) Sheet http://ybcc.com/role/OtherReceivableDetailsNarrative 4. Other Receivable (Details Narrative) Details http://ybcc.com/role/OtherReceivable 35 false false R36.htm 00000036 - Disclosure - 5. Prepaid Expenses (Details) Sheet http://ybcc.com/role/PrepaidExpensesDetails 5. Prepaid Expenses (Details) Details http://ybcc.com/role/PrepaidExpensesTables 36 false false R37.htm 00000037 - Disclosure - 6. Property and Equipment (Details) Sheet http://ybcc.com/role/PropertyAndEquipmentDetails 6. Property and Equipment (Details) Details 37 false false R38.htm 00000038 - Disclosure - 6. Property and Equipment (Details Narrative) Sheet http://ybcc.com/role/PropertyAndEquipmentDetailsNarrative 6. Property and Equipment (Details Narrative) Details 38 false false R39.htm 00000039 - Disclosure - 7. Intangible Assets - Net (Details - land use) Sheet http://ybcc.com/role/IntangibleAssets-NetDetails-LandUse 7. Intangible Assets - Net (Details - land use) Details http://ybcc.com/role/IntangibleAssets-NetTables 39 false false R40.htm 00000040 - Disclosure - 7. Intangible Assets - Net (Details Narrative) Sheet http://ybcc.com/role/IntangibleAssets-NetDetailsNarrative 7. Intangible Assets - Net (Details Narrative) Details http://ybcc.com/role/IntangibleAssets-NetTables 40 false false R41.htm 00000041 - Disclosure - 8. Commitments and Contingencies (Details) Sheet http://ybcc.com/role/CommitmentsAndContingenciesDetails 8. Commitments and Contingencies (Details) Details http://ybcc.com/role/CommitmentsAndContingenciesTables 41 false false R42.htm 00000042 - Disclosure - 9. Income Tax (Details - Income Tax Provision) Sheet http://ybcc.com/role/IncomeTaxDetails-IncomeTaxProvision 9. Income Tax (Details - Income Tax Provision) Details http://ybcc.com/role/IncomeTaxTables 42 false false R43.htm 00000043 - Disclosure - 9. Income Tax (Details - Deferred tax assets) Sheet http://ybcc.com/role/IncomeTaxDetails-DeferredTaxAssets 9. Income Tax (Details - Deferred tax assets) Details http://ybcc.com/role/IncomeTaxTables 43 false false R44.htm 00000044 - Disclosure - 9. Income Tax (Details - Reconcilation of tax rate) Sheet http://ybcc.com/role/IncomeTaxDetails-ReconcilationOfTaxRate 9. Income Tax (Details - Reconcilation of tax rate) Details http://ybcc.com/role/IncomeTaxTables 44 false false R45.htm 00000045 - Disclosure - 9. Income Tax (Details Narrative) Sheet http://ybcc.com/role/IncomeTaxDetailsNarrative 9. Income Tax (Details Narrative) Details http://ybcc.com/role/IncomeTaxTables 45 false false R46.htm 00000046 - Disclosure - 10. Equity (Details Narrative) Sheet http://ybcc.com/role/EquityDetailsNarrative 10. Equity (Details Narrative) Details http://ybcc.com/role/Equity 46 false false R47.htm 00000047 - Disclosure - 11. Non-Controlling Interest (Details) Sheet http://ybcc.com/role/Non-controllingInterestDetails 11. Non-Controlling Interest (Details) Details http://ybcc.com/role/Non-controllingInterestTables 47 false false R48.htm 00000048 - Disclosure - 12. Related Party Transactions (Details - Income Stmt) Sheet http://ybcc.com/role/RelatedPartyTransactionsDetails-IncomeStmt 12. Related Party Transactions (Details - Income Stmt) Details http://ybcc.com/role/RelatedPartyTransactionsTables 48 false false R49.htm 00000049 - Disclosure - 12. Related Party Transactions (Details - Accounts Receivable) Sheet http://ybcc.com/role/RelatedPartyTransactionsDetails-AccountsReceivable 12. Related Party Transactions (Details - Accounts Receivable) Details http://ybcc.com/role/RelatedPartyTransactionsTables 49 false false R50.htm 00000050 - Disclosure - 12. Related Party Transactions (Details - Due to related parties) Sheet http://ybcc.com/role/RelatedPartyTransactionsDetails-DueToRelatedParties 12. Related Party Transactions (Details - Due to related parties) Details http://ybcc.com/role/RelatedPartyTransactionsTables 50 false false R51.htm 00000051 - Disclosure - 13. Major Suppliers and Customers (Details Narrative) Sheet http://ybcc.com/role/MajorSuppliersAndCustomersDetailsNarrative 13. Major Suppliers and Customers (Details Narrative) Details http://ybcc.com/role/MajorSuppliersAndCustomers 51 false false All Reports Book All Reports ybao-20180630.xml ybao-20180630.xsd ybao-20180630_cal.xml ybao-20180630_def.xml ybao-20180630_lab.xml ybao-20180630_pre.xml http://fasb.org/us-gaap/2018-01-31 http://fasb.org/srt/2018-01-31 http://xbrl.sec.gov/currency/2017-01-31 http://xbrl.sec.gov/dei/2018-01-31 http://xbrl.sec.gov/country/2017-01-31 true true ZIP 70 0001683168-18-002356-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001683168-18-002356-xbrl.zip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end